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IHTSODUCTION 
The interferon system has become recognized as a major 
natural defense mechanism against viral diseases. It is 
believed to play an important role in the recovery from viral 
infections and serves to limit virus spread through the blood 
stream (10, 110), There is good evidence that interferon and 
interferon inducers prevent some neoplaistic diseases caused 
either by DNA (125, 160) or MA (83, 111) viruses. The pro­
tective effect of interferon and interferon inducers against 
trek's disease (MD) in chickens has not been extensively 
studied. Polyriboinosinic-polyribocytidylic acid (polyl* 
polyC), a potent synthetic interferon inducer (54, 83), has 
been reported to inhibit or delay the appearance of a 
number of tumors ^  vivo (83, 108, 134) and in vitro (51, 
l4lj 142). However, Nemes e;fc al. (123) reported that 
polyl'polyC gave no protection against MD in baby chicks. 
Recently it was reported (l6) that the administration of 
statolon parenterally to baby chicks within seven days after 
hatching has a prophylactic effect and is effective in 
•Î mT^ r»i->TT"î nty tffo-î erlwh crefivte: 4 /»>*•< r»Vat»)a f m hXT\ 
Interferon response may be altered by various factors. 
It has been reported that chemical carcinogens like urethan 
and polycyclic aromatic hydrocarbons depress interferon 
production ^  vivo (46) and ^  vitro (47), High concentra­
tions of arsenicals inhibit both th@ synthesis and the action 
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of interferon (62), 
Among the natural substances that man concentrates in 
his immediate environment, lead is one of the most ubiquitous 
(31). The most common sources of lead include lead-contain­
ing gasoline, used crankcase oil, machinery grease, lead-con­
taining paints, pesticides and insecticide baits (31). Even 
with the increased awareness of lead toxicity today, it 
still continues to be a common toxicant of livestock, pets 
and man. 
Lead interferes with numerous biological functions in 
the body (41). Subclinical doses of lead influence resis­
tance to bacterial invasion and the immunologie reactivity 
of the host. Williams et al. (1?8) suggested that lead may 
inactivate antibodies. It was reported that subclinical 
intravenous (I.V.) doses of lead acetate increase seasi-
tivity of the to endotoxin of various Gras negative 
bacteria by 100,000 times (147) and chicken sensitivity at 
least 1,000 times (l6l). Subclinical doses of lead nitrate 
suppressed mouse resistance to Salmonella typhimurium (81). 
It is possible that lead has a suppressive effect on 
interferon synthesis or action and this could be one of the 
variety of mechanisms by which metals induce or activate 
the oncogenic viruses already present in the host. 
The purpose of this study was to investigate the 
prophylactic and therapeutic effects of interferon and the 
interferon inducer ststolon against HD in chicksns» The 
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MD virus (MDV) can serve as a model for the study of DNA 
virus-induced neoplasms. Very little is known about the 
sensitivity of DNA viruses to interferon and the effect of 
interferon and interferon inducers on DNA virus oncogenesis. 
An additional objective of this study was to determine 
the effect of long term lead exposure on interferon pro­
duction in chickens. 
LITSBATUBE BEVIEW 
Interferon 
The role of a specific protein called interferon in 
the resistance of cells to viral infection was observed and 
described by Isaacs and Lindenmaan (91) in 1957• They in­
cubated cells from chorio-allantoic membranes with inactivated 
influenza virus and found an extracellular substance that 
interfered with the replication of live influenza virus. 
They conclucLed that the sstraccllular product had been pro= 
duced in response to the inactivated influenza virus and 
that this substance could confer viral iimunity on other 
cells. 
Subsequent work by many investigators in virology, 
biochemistry and molecular biology has added much informa­
tion about interferon. It is now known to be a protein of 
cellular origin which is capable of initiating non-specific 
intracellular inhibition of viral replication (91, 110). 
Interferon inducers 
Originally only viruses were thought to be capable of 
inducing the production of interferon (91). Subsequently 
various other agents have been shown to elicit the inter­
feron response. Gras negative bssteria bacterial 
endotoxins (S3, 110), rickcttsias (S5, 110), protozoa (110), 
mitogens (83, 110), synthetic materials (83, 85, 110), 
chlamydia (85), fungi and fungal extracts (85)» anti= 
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biotics (85, 110), statolon (100) as well as different live 
and inactive (85, 110) viruses have been shown to be inter­
feron inducers. With the exception of viruses and certain 
synthetic materials, most of these agents are not highly 
effective interferon inducers (85). 
Statolon, a fermentation product of a mould, Pénicillium 
stoloniferusi (100) represents one of the most effective 
interferon inducers known. Its interferon-inducing activity 
has been shown to be associated with virus-like particles 
found in the mould (52). 
Viruses of all the major groups can act as interferon 
inducers (110). The most effective inducers are members of 
the orthomyxovirus, paramyxovirus and togavirus groups (58). 
In general, enveloped ENA-containing viruses seem to be the 
best inducers of interferon (83), but DNA-containing viruses 
also induce interferon (83, 85). The ability to induce 
interferon varies greatly among strains of the ssas virus 
(156). 
The synthetic double-stranded SNA copolymer polyl'polyC 
is one of the most potent inducers of interferon has 
high antiviral activity vivo and in vitro (54, 55, 83). 
Another complex, polyriboadenylic-polyribouridylic acid 
(polyAopolyU) is less active and double-stranded complexes 
of DNA or deoxyribohomopolysers do not induce interferon 
(55, 110). 
Some coaaaon structural requirements of the synthetic 
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inducers must be kept in mind, namely, a sufficiently high 
molecular weight (42, 55)» regular and dense sequences of 
negative charges on a long-chain backbone (42) and intact-
ness of the double-stranded complex (29, 42). The integrity 
and molecular weight of polyl is much more important than 
that of polyC in determining the antiviral activity of the 
polyl*polyC complex (28)» The potential utility of double-
stranded ENA's as antiviral agents is constrained in part 
by a wide spectrum of toxicities (83), The toxicities 
appear to be related primarily to the presence of double-
helical RNA (28, 29); the single-stranded compounds have 
little or no toxicity (131). Since polyC appears to have 
a "passive® role in induction, it is the candidate strand 
for further modifications to permit accelerated hydrolysis 
of the complex (28), 
Other synthetic substances such as pyran copolymers 
(118) and polyacrylic acid (49) have recently been reported 
to induce interferon. The pyran copolymer appears to be of 
limited practical interest because of the large dose re­
quired to induee iaterferon and because of the Isek cf 
biodégradation (83)* 
Tilorone hydrochloride has been reported to be an orally 
active antiviral agent against different EKA and DNA viruses 
in mice (104)» Recently it %ss reported that tilorone 
hydrochloride is neither safe nor effective in man (95)o 
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Host response to interferon inducers 
Interferon has been produced by and shown to be active 
as an antiviral system in the living host or cells of many 
species of vertebrates (110 )• Viral inhibitor substances 
resembling interferon have been described in plants too (137). 
There is a marked difference in interferon-producing 
ability between species» Even individuals from the same 
species have been found to differ considerably in their 
capacity to produce interferon (58). 
The spleen, bone-marrow, lung and to a lesser extent 
liver and peripheral lymphocytes are the most important 
sites of interferon formation vivo following intravenous 
(I.V.) injection of inducers (58, 85). The relative impor­
tance of those tissues may differ for different inducers, 
animal species, age and routes of injection (26, 58, 110), 
Si-atolon adninlstsrsd intratrachsally (I.T. ) in chickens was 
practically ineffective as an interferon-inducer in the 
trachea or serum (56; 132)= However, when administered I.V. 
or intramuscularly (I.M.) it induced high levels of circu­
lating interferon (56, 132). On the other hand, polyl'polyC 
given I.V. did not produce circulating interferon, nor did 
it protect the chickens from challenge #ith the influenza 
virus (132). It was reported that although polyI*polyC is 
a relatively poor interferon-inducer in chickens when given 
I.M. or I.V., it can induce interferon and viral resistance 
in the trachea when given locally (56). 
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à number of different inducers stimulate production of 
interferon in chickens. Viruses like Newcastle disease virus 
'NDV) (11, 113), Marek's disease virus (MDV) (18?), Chi#_ 
kungunya (11), Sindbis (11), influenza (11) as well as stato-
lon (56, 132) are potent inducers, Tilorone hydrochloride 
(132) and polyl'polyC (56, 132) are poor inducers of circu­
lating interferon in chickens* 
The presence of a small amount of interferon or the 
absence of detectable interferon in serum is not an indication 
of protection or lack of protection (5^ )» Interferon pro­
tection can be confined to a specific organ depending upon 
the interferon inducer used and its route of administration 
(56). 
Mechanism of interferon production and action 
The mechanism of interferon production is not yet 
understood and two hypotheses for the mechanism of induction 
have been proposed. One involves the novo synthesis of 
interferon and the other the release of prefcnaed interferon 
(110)c Living agents such as viruses appear to induce syn­
thesis of interferon novo by derepression of the host 
genome to form a mRKA for synthesis of the corresponding 
interferon molecule (110, 112^  16?)* Biological extracts 
such as endotoxin and synthetic polyanions have been thought 
to release preformed interferon (110, 167). The distinction 
between the two patterns of induction has been baised on 
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relatively indirect arguments such as a different sensi­
tivity to inhibitors of SNA and protein synthesis and 
different kinetics of interferon production (42), A likely 
possibility is that each type of response requires ^  novo 
synthesis but that during viral induction additional steps 
occur such as uncoating of virions and formation of double-
stranded RNA, which are more sensitive to metabolic inhibitors 
than interferon itself (43). 
The observation of the phenomenon of superinduction in 
which inhibitors of protein synthesis actually enhanced inter­
feron production (30) cast doubt on the novo and preformed 
interferon induction hypotheses. To explain this enhance­
ment it was speculated that metabolic inhibitors might prevent 
synthesis of a repressor substance which normally shuts off 
interferon production (16?, 168). The superinduction phe­
nomenon ^  vivo cannot be entirely explained by inhibition 
of synthesis of a repressor (30). It is possible that inter­
feron is one of the several proteins which may be released 
into the circulation when cells are disrupted by cyclohex-
imide or other compounds (30). Cycloheximide causes low 
level interferon production ^  vivo but not ^  vitro (30), 
It is possible that low levels of interferon produced by 
various stimuli (e.g. gut bacterial endotoxin or viral 
infections) in animals keep the clearance mechanism at least 
partially saturated with interferon which is released by the 
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cell-destructive effects of cycloheximide (30). 
The derepression hypothesis of interferon production 
is widely accepted but it is not proven. None of the genetic 
elements of the interferon system have been isolated or 
characterized and likewise the molecule which triggers the 
depression of the host genome is not known for certain (112). 
The high interferon-inducing capacity of double-stranded ENA 
of both viral and synthetic origin in contrast to the 
inactivity of single-stranded ENA and double-stranded DNA 
was the basis for the hypothesis that the double-strandedness 
of RNA provides the final derepression for formation of aBNA 
and interferon (55). In. 19^ 9 Colby and Duesberg (39) demon­
strated the presence of a virus-specific double-stranded BKA 
in chick cells infected with vaccinia virus which could 
explain the stimulation of interferon by DNA viruses, Bakay 
and Burke (8) think that neither viral DNA nor RNA are 
necessary for interferon formation with DNA viruses. They 
feel that some virus function, as yet unidentified, is 
necessary for interferon production. Lockart (112) stated 
that he could find no evidence indicating that double-stranded 
RNA or viral protein is responsible for induction of cells 
to produce interferon. He believes that the cell itself 
provides inducer molecules to a wide range of stimuli (112), 
The mode of interferon action has been studied in 
viral infections and it was observed that interferon does 
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not act directly on virus (60, 84, 112). Interferon does 
not prevent virus attachment to the cell or penetration 
(60, 84, 93). Instead, it blocks the synthesis of new virus 
within the cell (60, 84, 93). 
Experiments with protein and SNA synthesis inhibitors 
suggest that interferon might induce the synthesis of another 
protein by derepression of the host genoa© and transcription 
of the specific mENA (60, 84, 93). This second protein, 
translation inhibitory protein (TIP), prevents the synthesis 
of new virus (60, 84, 93). Interferon or hypothetical TIP 
may act at the ribosomal level by interrupting the synthesis 
of viral-coded proteins which are required for virus multi­
plication (60, 84, 93). Ribosomes of interferon-treated 
cells have not been observed by some workers to form poly­
some complexes with the viral mENA (84, 93). Others reported 
that ribosomes would combine with but not translate viral 
mRNA (116). 
Interferon has been observed to have protective effect 
against phylogenetically higher organisms. Non-viral agents 
such as protozoa (140), bacteria (69). chlaawdia (79) and 
rickettsiae (96) were reported to be inhibited by interferon 
and various interferon inducers. Interferon and interferon 
inducers suppress intracellular replication of Shigella 
flexneri in human and rabbit cell cultures (69)o Since 
bacteria contain their own functional ribosomes, it now 
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seems unlikely that the ribosome is the only target of inter­
feron action. Huang e;t (89) have proposed that interferon 
and interferon inducers suppress phylogenetically higher 
organisms by enhancement of phagocytosis. 
Recent evidence implicates transcription of viral BNA 
as the basic defect in the virus replication mechanism in 
interferon-treated cells (14). It was also reported that 
interferon preparations have a growth-depressing effect on 
L-cells by inhibiting DNA synthesis (I50). The authors 
hypothesize that viruses which are sensitive to interferon 
have as a requirement for their replication some mechanism 
which is modified by interferon and which is normally asso­
ciated with cellular DNA synthesis (I50). 
It is apparent that an important factor which determines 
the susceptibility or resistance of a given virus to inter­
feron is the host cell in which the virus infection occurs 
(78). Youngner e^  al. (180) reported that in the same cell 
a DNA virus can be refractory to interferon and a RNA virus 
can be susceptible. They raised the possibility that separate 
resistance factors -say exist for RNA and DNA viruses (180). 
Factors influencing the induction, production and action 
of interferon 
The interferon response may be altered by various 
factors. Stress (154)» hormones (60, 133)> mycoplasma (152), 
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arsenicals (62) and chemical carcinogens (46, 4?) have 
suppressive effect. 
Corticosteroids given in amounts above the usual 
physiological level inhibited the interferon response to 
endotoxin (133) and virus (1^ 4). 
Chemical carcinogens like urethan and polycyclic aro­
matic hydrocarbons depress interferon production in vivo (46) 
and ^  vitro (47). The noncarcinogenic counterpart benzo(e) 
pyrene did not affect the interferon response (47), This 
suggests a correlation between carcinogenicity and 
inhibition of interferon synthesis (47). 
High concentration of arsenicals inhibited both the 
synthesis and the action of interferon (62), whereas low 
concentrations increased the antiviral activity of low levels 
of interferon (62). 
Development of tolerance or refractoriness to repeated 
stimulation by interferon inducers is an important phenomenon 
in animals (85). Stimulators, be they virus, endotoxin or 
polyl'polyC, cause tolerance in animals which then remain 
tolerant to subsequent infection for 4 to 13 days after 
which they are again sensitive (85), Dextran has been 
reported (50) to eliminate the hyporeactive state. The 
mechanism of refractoriness is obscure. Some authors feel 
that interferon production somehow produces a negative 
feedback for its own production (85). A humoral factor has 
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also been suggested (42) -while Vilcek (16?) has proposed that 
an endogenous cellular inhibitor participates in refractori­
ness. 
Properties of interferon 
The physical and chemical properties of interferon 
have been determined by studying impure preparations and the 
extent to which impurities have contributed to the observed 
properties is as yet unknown (53). 
The protein nature of interferon was first described 
by Isaacs and Lindenmann (91). Interferon is retained by 
dialysis membranes (91)s it is inactivated by proteolytic 
enzymes (91), but not by nucleases or ether (53» 91) which 
suggests the absence of nucleic acids and lipids as essential 
components of interferon. Only little is known about the 
ferons are or at least contain protein (53) a carbo­
hydrate moiety (53). 
Interferons are stable over a wide range of pH ranging 
from pH2 to 12 (53), they cannot be sedimented by centri-
fugation at 100,000g (53» 91) and they are relatively heat 
stable (91). The isoelectric point varies from pH 5.0 to 
10.0 (53) depending on its origin, inducer and host system 
(53). Disulfide bonds are required for interferon activity 
(119). Some, but not all, interferons ere inactivated by 
urea (119). 
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Interferons are heterogeneous with regard to molecular 
weight and the presence of multiple molecular species in a 
single interferon preparation has "been reported (53). The 
range of molecular weight of interferon is very wide and 
varies from 28,000 to 160,000 (60), Carter and Pitha (27) 
think that human and mouse interferons are not a group of 
heterogeneous proteins. Rather they exist in multiple 
oligomeric forms and different inducers seem to trigger the 
release of different oligomeric species (2?)» 
Several properties are shared by all interferons. 
Their mode of biological action is essentially species specific 
(58, 91). However, there are a few exceptions to the species 
specificity rule. Cross reactivity has been observed among 
species as different as mice and chickens (6?), A clear 
exception to this general rule is the cross reactivity 
between interferons of man and rabbit (48); viral-induced 
interferon from human skin fibroblasts showed 20 times more 
antiviral activity in rabbit kidney cells than in the human 
cells (48). 
It appears that interferon and antibody production are 
both highly specific functions of the lymphoid and reticulo­
endothelial (RE) systems and not merely consequences of non­
specific stimulation of the RE system (43). Although inter­
ferons are proteins, they are poor antigens (127). 
Interferons are active in a broad variety of viral 
JL6 
infections (42, 91, 110) and a large number of different 
viru«<es, "both SNA and DNA are susceptible to interferon 
action. 
Interferon has been observed to have protective effect 
against phylogenetically higher orgeinisms (69, 79, 96j 140). 
Interferon may act as a primer for its own production, 
Pretreatment of cells with interferon prior to viral induction 
results in earlier release and higher titers of interferon 
even by viruses which fail to induce without pretreatsent (9). 
Interferon-containing preparations were found to enhance 
phagocytosis (89). 
Biological role 
It is widely assumed that interferon plays a major 
role in recovery from viral infections (10, 110). Measurable 
antibodies appsar later szid ars sore active in inhiuitlmg the 
late spread of virus through the organisa or in preventing 
reinfection (10. 110). Persons who suffer from agaiainaglobu» 
linemia or hypogaamaglobulinesia ezperience great difficulty 
in combating bacterial infections but recover from most of the 
viral diseases (110). Interferon limits virus spread through 
the blood stream (10), It appears that interferon and anti­
body complement each other in their function in the living 
organism (68), The action of interferon is lisited by its 
rapid clearance from the circulation (110). In the serum of 
different mammals exogenous interferon I.v. injected has a 
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half life of 7 to 11 min, (86). The rapid loss from the cir­
culation can "be attributed to metabolism by cells and excre­
tion (86), Interferon, while broad-spectrum in its action 
against different viruses, does require a close phylogenetic 
relationship between the host species used to produce the in­
terferon and the species in which it is to be used (83, 110). 
All these limitations to the use of exogenous interferon in 
antiviral therapy suggest that endogenous stimulation may be 
another approach in practice (83). To be considered for 
application in clinical medicine the interferon inducers 
should be highly active, noninfectious, nontoxic and suf­
ficiently nonantigenic to allow repeated use (83, 110), 
A wide variation in the response of different viruses 
to inhibition by interferon has been observed (75). The 
togaviruses, vesicular stomatitis virus and vaccinia virus 
«•k — .3  ^  ^^   ^^  ^   ^^  4» M A «A ^  X  ^4 mm ^  «iM* GH C «..^ WXi.0 ^ U.OX'<9U. vue lUW/e U IT <0 V .fcWW/o = 
viruses, adenoviruses and the double-stranded ENA reovirus 
are relatively resistant (75» l68). Interferon suscepti­
bility of viruses even of the sase taxonosic group, varies 
depending on the virus strain, host systes and inducer used 
(58, 168). 
There is good evidence that interferon and interferon 
inducers can exert an antitumor effect in experimental 
animals inoculated with oncogenic viruses (73, 105? 108, 
130, 134, 160, 175)» with transplantable tusor cells (74) 
or with chemical carcinogens (111). 
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Repeated interferon administration significantly in­
creased the survival time of mice infected with Eauscher 
virus (73) and markedly increased survival of tumor-inoculated 
mice (74). Exogenous interferon preparations inhibited cell 
transformation by mouse sarcoma (130) and SV 40 (l60) viruses, 
Rous sarcoma and lymphoid leukemia viruses were found to be 
sensitive to the effect of exogenous interferon which in­
hibited their replication in tissue culture and the develop­
ment of tumors in chickens (105). Wheelock and Larke (176) 
reported that Sendai virus, statolon or repeated injections 
of interferon, each significantly prolonged the life of mice 
when administered even 30 days after Friend virus inoculation, 
at the time when mice were beginning to die of leukemia. 
polyl'polyc was reported to inhibit or delay the 
appearance of experimental tumors vivo (108, 134, 142) 
and in vitro (^ l, I4i, 142), In addition carcinogenesis by 
dimethylbenzanthracene (DHBA) is strongly inhibited by 
suitable administration of polyl'pclyC (111). Hovrever, 
polyl'polyC did not protect chickens against Karek's disease 
(123). 
Statolon was reported (142, 175, 176, 177) to be very 
effective in inhibiting viral oncogenesis in mice, Statolon 
prolonged the life of mice even when it was administered 
30 days after Friend leukesia virus (176), Recently it tras 
reported (I6) that the administration of statolon paren-
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terally to chicks within seven days after hatching has a pro­
phylactic effect, improves the weight gains and reduces gross 
lesions in chickens exposed to Marek's disease, 
Gazdar and Ikawa (64) and Gazdar e;t al« (65, 66) re­
ported that polyl'polyC enhanced virus-induced sarcomas and 
leukemias in mice and rats. Enhancement was dependent on 
multiple factors including the mouse strains, age and time of 
treatment. Pretreatment with polyl'polyC, polyA-polyU and 
other polynucleotides enhanced tumor induction by Moloney 
mouse sarcoma virus (MSV), but treatment with polyl, polyC, 
and polyA'polyU'polyU had no effect. A correlation exists 
between the MSV enhancement and the antiviral properties of 
polynucleotides (640. Lack of correlation was observed be­
tween titers of circulating interferon and MSV tumor enhance­
ment (65, 66) and suppression (173). Tumor enhancement 
could be due to alteration of immune response^  increased 
cell penetration or growth of tumor viruses (65, 65, 66). 
Gazdar e^  al. (66) think that suppression of MSV oncogen­
esis by high doses or continuous treatment with polyl«polyC 
may be mediated by a direct toxic or chemotherapeutic effect 
of the polyl'polyC on the hose or tumor cell. 
The mode of antitumor effect of interferon and inter­
feron inducers is unknown. Does interferon inhibit the 
replication of virus, multiplication of tumor cells directly 
or does it in some manner enhance the host's ability to 
reject the tumor? Some scientists feel that besides its 
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antiviral properties interferon increases the immune reactiv­
ity of the host (111). It was recently observed that inter­
feron preparations enhance antibody formation and graft vs. 
host reaction (19). An apparent lack of correlation between 
serum interferon levels and antitumor activity has been 
observed (173). The mechanism of antitumor action of 
polyl'polyc and statolon is multifaceted (5, 111, 177). 
Since both are potent interferon inducers, it is likely that 
part of the antitumor action is through the interferon system 
(111). Synthetic polynucleotides have been shown to induce 
cellular resistance to VSV in the absence of detectable 
interferon in cell culture (169). Considerably higher con­
centrations of polyl'polyC are required to produce demon­
strable interferon in cell culture (169). It has been 
assumed that cellular resistance produced by low polyl+polyC 
concentrations are mediated by endogenous ceiluisr inter­
feron (27, 169). Polyl'polyC was reported to enhance both 
humoral antibody formation and cell-mediated rejection (162). 
It also has direct chemotherapeutic action by inhibiting 
macromolecular synthesis in tumors ^  vivo, while having 
less inhibitory action on synthesis in normal organs (111). 
It is also suggested that rather than acting through inter­
feron induction, low concentrations of polyI«polyC may 
directly interfere with virus replication by binding to the 
virus-specific RNA polymerase (98). 
Badger et al. (5) believe that the polyl'polyC exerts 
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a cytotoxic effect "by damaging the DM as its primary anti­
tumor activity. It was reported that cyclic AMP inhibits 
tumor cells in vitro and restores a normal phenotypic char­
acter in neoplastic cells exposed to cyclic AMP (88), Since 
interferon and interferon inducers increase activity of 
adenyl cyclase and cyclic AMP levels (19, 172) antitumor 
activity of interferon may also be attributed to cyclic AMP. 
Wheelock (177) indicated that the antitumor effect of statolon 
might be due to its capacity to restore immuno-competence to 
mice infected with Friend virus since this virus induces an 
iminuno-depressive state» 
Marek's Disease 
Marek's disease (KD) first described by Marek (117) in 
1907 is probably the most common lymphoproliferative disease 
of chickens^  The etiological agent of MD was reported to be 
a cell-associated herpesvirus (36, 121, 155). Enveloped 
cell-free virus was extracted from the feather follicle 
epithelium (23, 122). 
The %D virus can be propagated in cell cultures, in 
chickens or in embryonated eggs. Infection may result in 
cytopathic effect (CPS) as with chicken kidney or duck 
embryo fibroblast cells, or may be without observable 
effects (240. In vivo, the effects of infection vary from 
degeneration of lymphatic tissues to oncogenesis. The nature 
of the oncogenic response is not understood (24), Viral 
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plaques develop on the chorio-allantoic membranes (CAM) of 
chicken embryos following yolk-sac inoculation with MD virus 
(15). Blood or tumor suspensions inoculated into susceptible 
baby chicks are very often used for transmission of the 
virus (24). 
Differences between isolates of MDV are apparent 
principally in their virulence and in tissue distribution 
of gross lesions (24). Serologically isolates appear to be 
indistinguishable (I36) except for cell-culture-attenuated 
isolates which lack an antigen demonstrable in virulent 
isolates (37). 
Feather follicle epithelium and perhaps feathers are 
thought to play an important role in the transmission of the 
disease by providing the enveloped virus, whether cell-free 
or within dead cells, which can survive in the environment 
or spread frca bird to bird (12). Other potential means of 
virus spread include the darkling beetle (Alphitobius diaper-
inus) and possibly other vectors (24). The existence of 
carrier birds has been reported (149). Egg transmission is 
insignificant in spreading the disease among progeny (40), 
The latent period is usually between three and four weeks 
in experimentally-induced MD in baby chicks (149). There is 
considerable variation in the latent period depending on vi­
rus strain, dosage, route of infection, genetic strain and sex 
of chickens (24), Clinical signs eosaoa. to the disease are 
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those associated with asymmetric, progressive paresis and 
later, complete paralysis of one or more of the extremities. 
Since any one or several of the nerves in the body may be 
affected, signs vary from one bird to another (24). Depres­
sion, shrill cheeps, ataxia, gasping, dehydration and ema­
ciation are very common (24', 102), Some birds die without 
extensive clinical disease (24), Blindness may result from 
involvement of the iris. Affected birds develop gross 
ocular lesions, show loss of normal pigmentation and paraly­
sis of the iris (24, 102). Tumors are commonly found in the 
gonads, liver, heart, preventricuius, muscle and skin (102), 
Morbidity and mortality are related to the virus strain, 
dosage and route of exposure. Host sex, genetic consti­
tution and age are very important factors (24), Organs 
associated with the immunological response, e.g. the bursa 
of Fabrlôiuô, trie thyâTûô cuid tiis wOiis zaïTOW; srs sitss of 
early virus replication «hich can result in necrosis, atrophy 
and aplasia of the organs (22)* The loss of lymphoid cells 
may have accounted for the decreased or delayed antibody 
response, lowered resistance to other disease and delayed 
homograft rejection all of which have been associated with 
MD (22, 128). According to Payne and Biggs (129) burseotomy 
coupled with X-irradiations reduced the incidence but did 
not eliminate the disease in exposed birdso This is la 
contrast to the situation with lymphoid leukosis whsro 
bursa of Fabrlcius is required for the development of the 
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disease (24). 
Antibody to MD acquired naturally from the dam, or 
injected prior to, or at the time of virus inoculation, 
failed to prevent infection but early destructive lesions of 
hematopoietic tissue were largely prevented (22). The 
presence of passive antibody at the time of virus entry can 
reduce the subsequent incidence of neoplastic lesions (35). 
Maternal antibodies (if present) are depleted by about three 
weeks after hatching (24). Since chickens are most sus­
ceptible to MDV when very young, hyperimmimization of the 
dams in commercial flocks can reduce losses due to the 
disease. Witter e^  (179) described a nonpathogenic 
herpesvirus from turkey (HVT) which is used for vaccine 
production. 
Biological Effect of Lead 
History 
Lead was one of the first metals discovered by man and 
has been widely used for domestic, industrial and medical 
purposes during the last two thousand years. Some of the 
clinical signs of lead poisoning ssrs knc«n to the «neients 
long before they were ascribed to the action of lead. 
Hippocrates (370 B.C.) was probably the first to recognize 
lead poisoning (4). He reported severe attacks of colic in 
a man who extracted metals. The Greek poet-physician 
Nicander first described the disease more than two thousand 
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years ago (4). Several reports about the development of 
lead colic appeared in the literature in the seventeenth 
century. Citois reported that wine contaminated with lead 
was the cause of colic (4), An experimental study of lead 
poisoning was conducted by Orfila in the nineteenth century. 
He administered lead orally as well as intravenously and 
reported that lead was more toxic orally (4). Gombault (70) 
reported a segmental demyelination in chronically poisoned 
guinea pigs. The soldering, painting and pottery industries 
constituted the largest industrial hazard during the nine­
teenth century leading to chronic lead poisoning in workers. 
Teleky (158), Oliver (124) and others did extensive work on 
the public and industrial hygiene aspects of lead poisoning. 
The decline of lead poisoning cases in the last two or 
three decades is likely a result of improved hygiene and 
medical supervision of *orkers iR the lead industry (76), 
Lead poisoning is still very common in ship and car building, 
storage battery and pottery industries (76), There is much 
evidence that lead wastes have been accumulating during the 
past century, particularly in congested urban areas (31). 
The most common sources are related to the burning of lead-
containing gasoline, used crankcase oil, machinery grease, 
lead-containing paints, pesticides and insecticide baits. 
Lead is one of the most common causes of child poisoning 
(32). 
The history of lead poisoning in animals is more 
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recent. Lead poisoning has been recognized as a factor in 
wa t e r f o w l  m o r t a l i t y  s i n c e  t h e  t u r n  o f  t h e  c e n t u r y  ( 7 ) c  
Morgan (120) in 1924 reported chronic lead poisoning in 
sheep and ponies and observed that animals might acquire a 
taste for lead. Gardner (63) reported development of ricketts 
in lambs when kept in lead-mining areas. Since then many 
reports have appeared in the literature concerning incidents 
of lead poisoning in many species of mammals (3» 33» 181) and 
birds (7,  38, 40, 159).  
Very little is known about lead poisoning in chickens. 
Signs of poisoning ascribed to the feeding of lead arsenate 
were described in 1932 (159). Salisbury e^  al. (144) re­
ported lead poisoning in chickens caused by feeding a grit 
which contained 32 per cent lead oxide, Simpson et al. 
(151) described abnormalities of erythrocytes and renal 
tubules of chickens poisoned with lead. 
Biological effects on the animal organism 
Although no population group is apparently as yet 
being subjected to levels of lead high enough to cause 
symptoms, it is clear that a continued rise, in the pollution 
of the human environment with lead could eventually produce 
levels of exposure that could have adverse effect on human, 
plant and animal health (31). The scientific literature is 
replete with reports on the toxic manifestations, diagnosis 
and treatment of lead poisoning. 
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As far as is known, lead is not a trace element essen­
tial to nutrition but this particular question has not been 
adequately studied (31). The usual daily dietary intake of 
lead in adult man averages about 0.3 mg. Of this, about 90 
per cent passes through the intestinal tract and is not 
absorbed. The small amount absorbed is also excreted and 
under normal conditions there is no net retention of lead in 
the body (97). Lead enters the body also through the respir­
atory tract and skin (97). When-the rate of lead absorp­
tion exceeds the rate of excretion, higher levels of lead 
result in the blood and metabolic, functional and clinical 
responses follow. At the level of cellular metabolism the 
best known adverse effect of lead is its inhibition of the 
activity of enzymes that are dependent on the presence of 
free sulfhydryl (SH) groups for their activity (171). Lead 
interacts with SH groups in such a way that they are not 
available to certain enzymes that require them. In the 
living organism, under most conditions this inhibition is 
apparently partial (171). The clearest manifestation of the 
inhibitory effect on the SH enzymes is the disturhanee lead 
causes in the biosynthesis of heme (31, 171). Lead is 
implicated specifically in the metabolism of delta-
amino-levulinic acid (ALA) and in the final formation of 
heme from iron and protoporphyrin. Both of these steps 
are mediated by mitochondrial enzymes. Almost all the 
information which exists on the effects of lead on the 
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synthesis of heme comes from observations of red blood cells 
(RBC). Yet all cells synthesize their own heme-containing 
products, notably the cytochromes (31). In the blood the 
functional effect of lead is anemia (31, 171). The decrease 
in heme synthesis leads at first to a decrease in the life­
span of RBCs and later to a decrease in the number of cells 
and in the amount of hemoglobin per cell (171). Lead in 
ionic form has a great affinity for RBC's, especially for 
their membranes and this interaction at excessive levels of 
lead brings on alterations of the BBC's and shortens their 
lifespan (41). In compensation, the blood-forming tissue 
steps up its production of BBC's and immature red cells, 
reticulocytes and cells with basophilic stippling appear 
in the circulation (31, 41, 171). The stippling represents 
remnants of the cytoplasmic constituents of red cell pre­
cursors such as clumps of ribosomes and mitochondria (92), 
Basophilic stippling was not seen in birds with lead toxi­
cosis (38, 151). However, dumbbell, bottle, oat, sickle 
and teardrop forms (38) and various stages of mitosis were 
observed in RBC's of birds exposed to lead (151)c 
A significant positive correlation between copropor-
phyrinuria and the occurrence of lead in the urine and the 
blood was reported (157). An increase in protoporphyrin 9 
in blood is one of the best indicators of lead poisoning 
(41). 
The activities of enzymes other than those associated 
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directly with hematopoeiesis are also influenced by lead. 
Increases in the activity of serum aldolase, serum glutamic 
oxaloacetic and pyruvic transaminases have been observed 
(170). Alkaline phosphatase activity diminishes significant­
ly in experimental animals exposed to toxic doses of lead 
(101). Enzymatic alterations associated with toxic effects 
exerted upon cardiac and skeletal muscle, small blood ves­
sels and the cells cf the liver, kidney, intestine and 
salivary gland have been reported (4l). Lead is capable of 
suppressing cellular oxidation-reduction processes and of 
inhibiting the active transport of high-energy organic 
phosphates in muscle (4l). Barked inhibition of succinate 
oxidation and ADP-stimulated respiration ^  vitro was 
reported (25). It is assumed that lead interacts with the 
mitochondrial membrane (41). 
In aeute lead poisoning observable changes in the 
kidney and kidney functions were reported (31)• Much of 
the excess lead is ' Oiicentrated in the form of dense acid-
fast inclusions in the nuclei of certain cells, including 
those lining the proximal renal tubules (72). These inclu­
sions consist of a complex of protein and lead (72), 
Apparently inclusioas serve as a protective device to keep 
lead in the nucleus. away from vulnerable mitochondria 
(72), Kidney dysfunction is expressed in what is called 
the Panconi Syndrome, characterized by loss of amino acids, 
glucose and phosphate in urine because the damaged tubular 
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cells fail to reabsorb these substances (72). Long term 
plumbism was implicated as a cause of a chronic nephritis 
(107). 
The toxic effect of lead on the central nervous system 
is little understood (31). Chronic overexposure to lead 
causes peripheral nerve disease, affecting primarily the 
motor nerves of the extremities. Mitochondria of the 
Schwann cells are damaged resulting in demyelinization 
(31). 
Striking changes were observed in the amount of various 
amino acids in the blood and liver of experimental animals 
exposed to lead (17). Decrease of alanine, cysteine, 
glutamic acid, leucine and methionine was very significant. 
Other animo acids, with the exception of lysine, were 
affected as well (17). 
Caccuri (21) reported a distinct relationship between 
lead poisoning and the metabolism of nicotinic acid. 
Animals poisoned by lead exhibit a profound decrease of 
blood nicotinic acid content with the consequent reduction 
of NAD and NAD?: Lead was reported to inhibit the bio­
synthesis of the DNÂ and ENA of E. coli (103)» It is sug­
gested that lead exerts serious effects upon the pyridine 
nucleotides, either by blocking their synthesis or by en­
hancing the degradation of nicotinic acid (41). 
It was reported that lead poisoning interferes with 
lipid metabolism leading to morphologic changes in arterial 
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walls similar to those seen in atherosclerosis in rats (146). 
Consistent body weight losses and emaciation were 
observed in birds which were given high doses of lead for 
prolonged periods (38, 15I). 
Metals rank among the most prominent industrial and 
environmental carcinogens. Arsenicale, chromium and nickel 
compounds are accepted as carcinogens for husazis. Iron, as 
hematite and iron-dextran, is strongly suspected (13). So 
far lead has not been shown to be a carcinogen in man but 
lead compounds obviously induce tumors in animals. Cerebral 
gliomas (126) and renal tumors in rats (18) and mice (163) 
were induced with dietary lead. 
Influence on immunologic responses 
There is considerable evidence that tozic substances 
exert adverse effects upon the resistance of the body to 
disease by influencing immunologic mechanisms, Fonzi et al, 
(59) have reported that lead-treated animals, subsequently 
subjected to procedures of active immunization, developed 
lesser quantities of gamma globulin, complement underwent 
lower. The activity of lysozyme is reduced in the spleen 
and serum of dogs poisoned by the prolonged administration 
of lead (1). Interference with phagocytic activity of 
polymorphonuclear leukocytes has been reported in cases of 
lead toxicity in man (138). Williaas et al, (178) suggested 
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that lead may inactivate antibodies. Lead has also been 
reported to bind antibodies ^  vitro and could potentially 
do so under vivo conditions (178). This ability to bind 
proteins could also interfere with the functional activity 
of the properdin and complement systems (81), It was re­
ported that the subclinical I.V. administration of lead 
acetate increases sensitivity of the rat to the endotoxin 
of various Gram-negative bacteria by 100,000 times (14?) 
and chicken sensitivity at least 1,000 times (161). Mice 
treated with subclinical doses of lead nitrate for thirty 
days showed greater susceptibility to challenge with Sal­
monella typhimurium than controls which received no lead 
(81). 
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MATERIALS AND METHODS 
Cell Cultures 
MDBK cells 
The Madin-Darby bovine-kidney cell line (MDBK) was used 
for interferon assay and for pseudorabies virus (PVE) propa­
gation. 
The cells were propagated in 250 ml plastic tissue-
culture flasks^  in Eagle's basal medium (BME) with Earle's 
salts^ , supplemented with 10 per cent newborn calf serum^  
and 0,11 per cent sodium bicarboziate. After trypsinization 
with a 0.2 per cent trypsin-versene solution (see later), 
the cells were diluted 1:3 in growth medium and 2 ml were 
inoculated per well into 35 % 10 mm wells of plastic tissue-
culture plates® and 20 ml into 250 ml plastic tissue-culture 
flasks, Monolayers usually developed in 2^  to 48 hours, 
CEP cells 
The primary chicken embryo fibroblast (CEP) cells were 
used for vesicular stomatitis virus (VSV) propagation, 
titration and interferon assay. 
CEP cells were prepared from ten and eleven-day-old 
F^alcon Plastics, Los Angeles, California, 
°Grand Island Biological Company, Grand Island, New York. 
°Linbro Chemical Co., New Haven, Connecticut. 
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embryos using a modification of a previously described tech­
nique (145). Eggs were obtained from the specific-pathogen-
free flock maintained at the Veterinary medical Research 
Institute, Iowa State university. Egg shells were disin­
fected over the air sac with 70 per cent alcohol and embryos 
were aseptically transferred into petri dishes containing 
saline G (see later). They were then decapitated, eviscer­
ated and their feet and legs were removed. Embryos 
were then transferred to a 35 ml syringe and forced with the 
plunger directly into a trypsinization flask containing 
0.2 per cent Ca-free trypsin^ . Trypsinization was per­
formed on a magnetic stirrer for 5 - 15 min. at .room temper­
ature until cells were dispersed. The trypsinized cell 
suspension was then centrifuged twice at 800 rpm for 10 
min. and resuspended in growth medium at a concentration of 
0,5 ml of packed cells per 100 ml aeu-iuin. Growth medium 
consisted of BME with Earle's salts, supplemented with 
5 per cent fetal calf serum^ , 10 per cent tryptose phosphate 
broth^  (TPB) and 0,11 per cent sodium bicarbonate. One ml 
of cells suspended in growth medium was used to inoculate 
each disposable glass tissue-culture tube°" and 2 ml per well 
D^ifco Laboratories, Detroit, Michigan, 
G^rand Island Biological Company, Grand Island, New York. 
""Grand Island Biological Company, Grand Island, New York, 
K^imble Glass Company, Toledo, Ohio, 
35 
in the 35 % 10 mm wells of plastic tissue-culture plates. 
Monolayers usually developed in 48 to 72 hours. Primary CEP 
cells were passed up to five times. 
Buffers and Diluents 
Saline G 
Sterile Saline G (135) was used as a virus diluent and 
during preparation of CEP cells. 
Phosphate buffer 
A O.OIM phosphate buffer (PBS) pH 7.5 was used as a 
dialysis solution for the serum and as the diluent in the 
hemagglutination (HA) and hemagglutination-inhibition (HI) 
tests. 
To prepare the phosphate buffer 8.5 ml of IM Na^ HPOj^  
and 1.5 ml of IM NaH^ PO^  were mixed and made up to one liter 
-with physiological saline solution. 
Buffer pH 2 
A O.IM KCl-HCl buffer (pH 2) was used as a dialysis 
solution for chicken serum prior to interferon assay. This 
buffer vîâs prepared by mixing O.IM KCi and O.lM HCl until 
the desired pH was obtained. 
Physiological saline 
Physiological saline solution was used to wash cell 
cultures during interferon assay by the dye-uptake method (57) 
and for interferon characterization experiments. 
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Mcllvaine-Lillie buffer 
This buffer (pH 4.2) was used for dye extraction in 
interferon assays by the dye-uptake method. Stock solutions 
of O.IM citric acid and 0.2M dis odium phosphate (NagHPOij, ' 
7H2O) were made in 25 per cent methanol. Stock solutions 
were diluted 1;25 in water before use and mixed until the 
desired pH 4,2 was obtained, 
A mixture of equal volumes of this buffer and absolute 
ethanol was used as the extraction fluid. 
Water 
The water used in all procedures and solutions was 
glass distilled and deionized. It routinely contained less 
than 0.05jpg/ml of sodium chloride equivalents as measured 
with a conductivity meter®. 
Eagle's basal medium with Earle's salts supplemented 
with 2 per cent newborn calf serum and 0.11 per cent sodium 
bicarbonate was used for the maintenance of cell monolayers, 
for the cell washing and as a diluent in the interferon 
titrations. The medium was filter sterilized, 
Trypsin-Versene Solution 
A trypsin-versene solution was used to remove cells 
from the surface of the flasks after propagation of the MDBK 
S Barnstead Company, Boston, Massachusetts, 
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and CEP cells. The formulation was as follows: 
Trypsin^  2.0 g 
NaCl 7.0 g 
KHgPO^  0.2 g 
Na^ HPOj^ ,^ 1.15g 
HgO 1 liter 
Ethylenediamine 
Tetraacetic acid, disodium 1.0 g 
salt (EDîA) 
Agar-Overlay Medium 
A double concentration of Eagle's basal medium with 
Earle's salts and supplemented with 10 per cent newborn calf 
serum and 0,22 per cent sodium bicarbonate was combined with 
an equal volume of 1.8 per cent Noble Agar^ . This was used 
as an agar-overlay medium giving a final concentration of 
ûo9 per cent agar, 5 per cent serum and 0.11 per cent sodium 
bicarbonate. Ten thousand units of penicillin and 10,000 
micrograms of streptomycin were used per 100 ml agar-overlay 
medium. 
Viruses 
Vesicular stomatitis virus 
The Vesicular stomatitis virus, Indiana strain (VSV-In) 
i^fco Laboratories, Inc., Detroit, Michigan. 
D^ifco Laboratories, Inc., Detroit, Hichigan. 
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at the unknown passage level was used. The third passage 
level on BHK cells was propagated on CEP cells in 250 ml 
tissue-culture flasks. When the cytopathic effect (CPE) was 
nearly complete, the growth medium containing virus and cells 
was frozen, thawed and centrifuged at jOOg in order to remove 
the cell debris and then stored at -90 C, VSV-In at the 
third and fourth passage levels on CEP cells was used 
for the interferon assay. 
Fseudorabies virus 
The Fseudorabies virus strain DR (PRV-DR) was isolated^  
on MDBK cells from the brain of a calf which died of pseudo-
rabies. PRV-DR was cloned three times on MDBK cells and was 
used as inoculum at the twelfth passage level on MDBK 
cells. 
O W J.XXX V U.X VLO 
The Shope strain of the swine influenza virus^  (SIV) of 
undetermined passage level was used= The virus was propa­
gated by allantoic-cavity inoculation of eleven-day-old 
chicken embryos. The virus was titrated by the HA test and 
used for interferon induction experiments, 
&Dr. C. J. Mare, College of Veterinary Medicine, Iowa 
State University. 
O^btained from Dr» W, P« Switzer, Veterinary Medical 
Research Institute, Iowa State University. 
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Newcastle disease virus 
The strain of Newcastle disease virus (NDV-B^ )^  
of undetermined passage level was used. The virus was propa­
gated by allantoic-cavity inoculation of eleven-day-old 
chicken embryos. The virus was titrated by the HA test and 
was used for interferon induction in chickens and chicken 
embryos, 
Marek's disease virus 
Sevoian's (148) virulent Marek's disease virus, the 
JM-V strain (MD-JMV), which causes lymphoblastic leukemia 
and death at five to ten days after inoculation into baby 
chicks, was used at an undetermined passage level in chicks. 
The virus was propagated by intraperitoneal (I.P.) 
administration of 0.2 ml MD-JMV to four-day-old chicks, 
4 o +• ^ ^  ^ 4 A all a A A TVA4WAA V/ A W V WWWk WW rt >-•* W y 
by cardiac puncture. Freshly-collected blood was pooled, 
stabilized with 5 per cent dimethylsulfoxide, put into 
2 ml ampoules, slowly frozen and stored in liquid nitrogen 
The virus was titrated in four-day-old chicks and the titer 
was calculated using the Reed and Muench method (139). The 
MD-JMV virus was used in Bxperimsnt I for chicken inoculation. 
Plaque Staining 
Crystal violet was used (174) for plaque staining, 
O^btained from Dr. M « S. Hofstsd. Veterinary Msdioal 
Research Institute, Iowa State University, 
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When visible plaques appeared under agar, 2 ml of a 10 per 
cent formalin solution was added to fix the cells in the 
35 X 10 mm wells of plastic tissue-culture plates. After 
15 Bin. the agar was removed, cell sheets were washed under 
tap water and 1 per cent crystal violet in 20 per cent 
ethanol was added for one minute. Stain was washed off 
under tap #ater and plaques were counted. 
Virus Titration 
Tenfold serial dilutions of VSV and PRV virus were 
made in saline G. One ml of each dilution of virus was in­
oculated into each of two 35 3C 10 mm wells of the plastic 
tissue-culture plates containing CEP monolayers. After an 
adsorption period of one hour at 37°C the virus was aspirated 
and the monolayers were overlayed with the agar-overlay 
medium, 2 ml per well, 'She plates were then incubated until 
plaques were seen. The crystal violet staining technique 
was then used. The titers of the viruses were expressed in 
plaque forming units (pfu) per ml, Marek's disease virus 
was titrated in chickens. 
Virus Propagation in Chicken Embryos 
Fertilized eggs were obtained from the specific-pathogen-
free flock maintained at the Veterinary Medical Research 
Institute J Iowa State University, The eleven=d£y®old chicken 
embryos were inoculated into the allantoic cavity with 0,1 ml 
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of NDV or SÎVo Inoculated eggs were incubated in a humidi­
fied 37 G incubator. As soon as death occurred, allantoic 
fluid was harvested, pooled and the virus was stored at 
-90 C. 
Purification and Concentration of Virus 
Purification and concentration of NDV and PSV were 
performed by centrifugation (164). When CPE was nearly com­
plete, the growth medium containing virus and cells was 
partially purified by centrifugation at 3G0g for 10 min» 
to remove cellular debris. The virus was then pelleted by 
centrifugation at 30,000g for 90 min. The pellet was sus­
pended in saline G and stored at -90 C until needed. 
Polyriboinosinic-Polyribocytidylic Acid 
Polyl'polyC® (serial number 76645) was used as the inter­
feron Inducer in ohickcns at the doses indicated later. 
The polyl'polyC was stored at 4 C in vials until used, 
Statolon 
Statolon^  (lot 354-1080B220) was stored in a desiccator 
at 4 C until used. Immediately before use, the powder was 
weighed and suspended in distilled water at the concentrations 
M^icrobiological Associates, Bethesda, Maryland» 
O^btained frcs Dr. J. Kleinschaidt, Eli Lilly and 
Co., Indianapolis, Indiana. 
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indicated later. The statolon was used as an interferon 
inducer in chickens as described later. 
Tube Hemagglutination Test 
Serial twofold dilutions of the allantoic fluid con­
taining NDV or SIV were made in PBS (pH 7*5)' Equal volumes 
of 0,5 per cent chicken erythrocytes in PBS (pH 7,5) were 
added to the virus dilutions and thoroughly mixed. The test 
was held for 60 min, at room temperature, A positive hemag­
glutination pattern consisted of a imlform thin layer of 
erythrocytes covering the bottom of the tube. The negative 
pattern consisted of a round "button" of sedimented cells. 
The reciprocal of the highest dilution of allantoic fluid 
which gave positive agglutination was considered to repre­
sent the titer of the virus. 
Tube Hemagglutination-lnhlbiticn Test 
The HI test was used to detect NDV antibody titers in 
chickens. The constant-virus and deereasing-serum method 
was used. 
Serial two-fold dilutions of the serum were made in 
PBS (pH 7,5)o Equal volumes (0o25 ml) of serum and KDV 
containing 80 HA units/ml were mixed and incubated for 60 
min, at room temperature. An equal volume (0,5 ml) of 0,5 
per cent chicken erythrocytes in PBS was added, the tubes 
were shaken and results were read after 60 min. at room 
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temperature. The endpoint of the inhibitory activity of the 
serum was the highest dilution of serum in which hemagglu­
tination was completely inhibited. The reciprocal of that 
dilution was considered to represent the antibody titer. 
Agar Gel Precipitation Test 
The agar gel precipitation (AGP) test was used to 
determine antibody titer to Marek's disease (34) in baby 
chickens. 
The plastic 60 x Ip mm dishes containing agar- which was 
prepared utilizing the method of Churchill e^  al, (37) 
were stored at 4 C in plastic bags until used, 
A central hole cut in the gel was filled with feather 
follicle antigen^  (77) and the surrounding six holes filled 
with test sera and positive control serum^ . The plates 
were then sealed and incubated at room temperature^  Re­
sults were recorded after five days when one or more clear 
precipitation lines were visible with control positive serum. 
Preparation of Exogenous Interferon 
The exogenous chicken interferon was used in Experi -
ment 1. 
Eleven-day-old chicken embryos were inoculated by the 
allantoic cavity route with 0,1 ml of NDV containing 
O^btained from Dr. P. D. Beard, USDA, APHIS, Veterinary 
Services, Ames, Iowa 
1280 HA/ml. Allantoic fluid was harvested at 60 hours 
postinoculation, pooled and dialyzed at 4 C against 100 
volumes of O.IM KCl-HCl buffer (pH 2) for 72 hours and 
then back dialyzed against PBS (pH 7.5) for an additional 
72 hours. Précipitants were removed by centrifugation at 
30,000g for 90 min. at 4 C and allantoic fluid was the a 
concentrated ten times by pressure filtration at 4'C. 
Pressure filtration was carried out in dialysis tubing^  
suspended in a flask maintained at a negative pressure 
of 15 pounds per square inch. Concentrated allantoic fluid 
was then sterilized by filtration through 300 nm Millipore 
filters^  and stored at -20 C until assayed for interferon 
activity. Bovine serum albumin^  (0.5 'Ug/ml) was added to 
stabilize the interferon during storage (106). 
The viral inhibitor produced in chicken embryos was 
considered to be an interferon since it was acid-resistant, 
non-dialyzable, trypsin sensitive and possessed species 
specificity. 
Serum Preparation for Interferon Assay 
Blood samples were collected from baby chicks by cardiac 
*0.25 inch EDP No. 3787-DlO, Arthur H. Thomas Co., 
Philadelphia, Pennsylvania* 
M^illipore Filter Corporations Bedfoirdp Massachusetts» 
P^entex Bovine Albumin, Research Product Division, 
Miles Laboratories J Inc,. Kanksnee, IllinoiSo 
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puncture. Jugular and wing vein bleeding was used in older 
chickens. After firm clots were formed at room temperature, 
the blood was incubated for 1-1,5 hours at 37 C and serum 
was harvested after centrifugation for 15 min, at 2,000 rpm. 
The sera were dialyzed in cellulose tubing at 4 C against 
O.IK KGl-HCl buffer (pH 2) for 24 hours and then against 
PBS (pK 7.5) for 24 additional hours. Precipitation developed 
in most specimens after dialysis and was removed by centri­
fugat ion at 30,000g for 60 min, at 4 C. The supernatant 
fluids were collected, filtered through 300 nm Millipore 
filters and stored at -20 G until assayed. Bovine serum 
albumin (0.5 ug/ml) was again added. 
Neutral Red 
Neutral red solution (1:20,000) was used in interferon 
assay. 
One and a half grams of neutral red^  was ground and 
mixed with absolute alcohol to give a 10 per cent (w/v) 
solution, diluted in water to 1 per cent, filtered through 
filter paper and autoclaved at ten pounds per square inch for 
20 min. and used as a stock solution. 
^National Aniline Division, Allied Chemical Corporation, 
Rochester, New York. 
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Interferon Assay 
Dye uptake method 
Exogenous chicken interferon prepared in chicken 
embryos was assayed by the dye-uptake method (57). 
Serial twofold dilutions of the dialyzed and centri-
fuged fluids were made in maintenance medium supplemented 
with 2 per cent heat=inactivatsd bovine serum. One ml of 
each dilution was inoculated into three 12,5 % 1,5 cm rubber 
stoppered glass tubes containing CEP monolayers and were 
incubated at 3? C for 16 to 18 hours. The cultures were 
then drained, washed twice with serum-free maintenance 
medium and infected with VSV containing 2 x 10 pfu/0,2 ml. 
Tubes were incubated at 37 C in a humidified atmosphere 
containing 5 per cent CO^  until marked cell destruction 
was seen in virus control tubes. Half ml of neutral red 
(1:20,000) was added to the medium in each tube. After 
two hours incubation at room temperature the medium was 
decanted and the cell sheets were drained by inversion 
and washed twice with 2 ml physiological saline. The 
dye from each tube was extracted into 2 ml of ethanol. 
buffered with an equal volume of Kcllvaine-Lillie buffer, 
pH 4,2, Dye solutions from replicate tubes were pooled 
and measured colorimetrically at 5^ 0 nm using a Bausch and 
Lomb Spectronic 20 Colorimeter, Interferon titer in $0 
per cent dye-uptake units was the reciprocal of the dilution 
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giving dye uptake midway between the virus and cell culture 
controls. 
Plaque reduction method 
This technique was used in Experiments II and III. 
Serial twofold dilutions of the dialyzed and centri­
fugea. serum were made in maintenance medium supplemented 
with 2 per cent bovine serum. One ml of each dilution was 
inoculated into each of two 35 x 10 îsm wells containing 
CEP monolayers and incubated at 37 C for 16 to 18 hours. 
The control wells were inoculated with 1 ml of the main­
tenance medium and were incubated for the same period of 
time. At the end of the incubation period the fluids were 
aspirated, the plates were washed twice with the maintenance 
medium and 1 ml of VSV (calculated to contain 50 to 100 pfu) 
was added to each T^ ell. After adsorption of ths virus at 
37 C for one hour the excess viral fluids were aspirated 
and the cultures were covered with an agsr-overlay aediumi 
After incubation until the visible plaques uere seen, 
crystal violet staining was useds The interferon titers 
were expressed as the reciprocals of the dilutions which 
produced 50 per cent reduction in the number of viral 
plaques when compared with the number in the control plates. 
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Characterization of Interferon 
Acid stability and dialyzability 
All samples were dialyzed for 24 hours against 50 to 
100 volumes of O.IM KCl-HCl buffer (pH 2) at 4C in cellulose 
dialyzer tubing. This was followed by a similar dialysis 
against PBS (pH 7.5) for 24 additional hours. The final 
samples were assayed for interferon activity as described 
previously. 
The representative pooled interferon-containing samples 
were tested for species specificity, heat stability, trypsin 
sensitivity and the effects of ultracentrifugation (I65). 
Suitable controls were included with each test. 
Host species specificity 
The interferon-containing samples produced in chickens 
were zested for their activity on HDBK cells by the plaoue 
reduction assay. 
Heat stability 
Heating of sera was performed in a water bath at 
56 C for 60 min. After the required length of time, sera 
were immediately diluted in a maintenance medium and 
assayed for interferon. 
Trypsin sensitivity 
Equal volumes of interferon-containing serum and a 
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solution of trypsin^  containing 2 mg/ml in physiological 
saline were mixed. This mixture was incubated for two hours 
at 37 G. After the incubation, serial twofold dilutions of 
the interferon were made in BME supplemented with 15 per 
cent heat-inactivated newborn calf serum and the interferon 
was assayed for antiviral activity against VSV on CEP cells. 
The number of plaques was compared with the controls which 
consisted of equal volumes of the interferon and physiologi­
cal saline solution incubated for two hours at 37 C. 
Ultracentrifugation 
The samples were ultracentrifuged in an International 
B 60 ultracentrifuge^  at 100,000g for 60 min, and the 
supernatant fluid was assayed for antiviral activity. 
Experimental Chickens 
M ii-L «V XA. nr ^ v.' v w v *• a ^ » w 
pathogen-free flock maintained at the Veterinary Medical 
Research Institute, Iowa State University, All the chickens 
for a given experiment were hatched together and subse­
quently held in the same wire-floored battery brooders in 
an isolation unit (Experiment I) or in wire cages (Experi­
ments II and III), Sera of the chickens used in Experiment I 
Michigan, 
"Trypsin 1:250, Difco Laboratories, Inc., Detroit, 
^International Equipment Co., Boston, Massachusetts. 
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were negative for Marek's disease (MD) antibody in the 
AGP test. 
Weights 
All birds used in Experiment II were individually 
weighed before and after lead treatment. 
Lead Acetate 
Lead acetate^  dissolved in water was used as a lead 
source for chickens at the doses indicated below. 
Determination of Lead in Blood 
Blood was collected from chickens into 100 x 16 mm 
Vacutainer tubes containing sodium heparin^  as an anti­
coagulant and was frozen at -20 C until tested. The method 
described by Hessel (82) for lead determination was used®. 
The blood was hemolyzed by using 5 per cent TX-lOO solution^  
and was chelated with ammonium pyrrolidine dithiocarbamate 
(APDC) and extracted by methyl isobutyl ketone. The organic 
supernatant solution was analyzed by atomic adsorption 
.^allinckrodt Chemical Works, St, Louis, Missouri, 
B^ecton, Dickinson and Co,, Columbus, Nebraska and 
Rutherford, New Jersey. 
A^nalyses for lead in blood and tissues were performed 
by J. Kurd, Veterinary Diagnostic Laboratory. Iowa State 
Univarsity, 
T^X-100 is alkyl phenoxy polyethoxyethanol, Rohm and 
Haas, Philadelphia, Pennsylvania. 
51 
spectroscopyo Standards were made using the "blood collected 
from chickens which were not exposed to lead. 
Standards having concentrations of 1, 2, 3» 4- and 5 
parts per million (ppm) of lead respectively, were made 
using Pb(N0^ )2. Thorough shaking of the standards was 
found to be a very important factor. 
Five ml of unclotted test blood collected from chickens 
were pipetted into 150 x 20 mm test tubes and 1 ml of the 
5 per cent TX solution was added to each. One ml of the 2 
per cent APDC solution was then added to each test tube 
followed by mixing. Five ml of water-saturated methyl 
isobutyl ketone was then added, test tubes were sealed with 
screw caps and were shaken for at least one minute by hand, 
followed by centrifugation for ten min. at 2,000 rpm. The 
organic supernatant was aspirated into an atomic absorption 
a 
spectrcphctcsîstsr~ at a wave length of 2S35à (range selector 
UV) and the burner was kept uMsr norssl flo% condition of 
air and acetylene as described by Hesssl ( 8 2 ) .  
Determination of .Lead in Tissues 
Tissues vrers «eighed into â porcelain crucible and one 
ml aqueous magnesium acetate solution (20 mg of magnesium 
acetate per ml of water) was added per gram of tissue (71). 
The crucible content was well dried on a steam bath and then 
®Perkin-Elmer Model 303, Perkin-Elmer Corp», Walthum, 
Massachusetts. 
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was ashed in a furnace at 450-475 C for four to five hours. 
The ash was dissolved in a 2 K hydrochloric acid and then 
diluted with water to an appropriate volume. The Perkin-
Elmer atomic absorption spectophotometer, Model 303» was 
used for all determinations. Instrument settings were those 
recommended in the Analytical Methods for Atomic Absorption 
Spectrophotometry (2), 
Hematological Procedures 
Disposable tuberculin syringes were used to collect 
blood from the wing veins of chickens. Blood was immediately 
transferred into 50 % 12 mm Vacutainer glass tubes with EDTA 
as anticoagulant. 
Blood from each sample was used for leukocyte, erythro­
cyte and differential counts and hemoglobin and packed cell 
volume (PCV) determinations. 
Total leukocyte counts were estimated using the Rees-
Sckep method as reported by Lucas stiu Jamroz (114), The 
total number of cells counted from the four corner squares 
of a hemocytometer counting chamber was multiplied by 50 
to give the total leukocyte count per cubic mm* 
Slide smears were air-dried and stained with standard 
Wright's stain®' for differential leukocyte counts, 
H^arleco, Philadelphia, Pennsylvania, 
53 
Erythrocyte counts were made using a Coulter counter^  
(80). 
Packed cell volume was determined by the micro-hemato-
crit method using capillary tubes. The tubes were heat-
sealed and centrifuged at 15,000 rpm for three minutes. 
The percentage of packed erythrocytes was determined. Hemo­
globin values were determined using the cyanmethemoglobin 
technique (80), 
Necropsy Examination 
Birds that died during the course of the experiments 
were necropsied. 
All surviving birds in Experiment I were necropsied 
six weeks after administration of virus. 
Pour chickens selected at random from each of the 
treatment groups in Experiment II were necropsied at the 
time of death or 35 days after the start of lead administra­
tion. Gross lesions were observed and liver, kidney and 
lung samples were fixed in 10 per cent buffered formalin 
and processed for histopathologic examination. The lung, 
liver, kidney, brain, bone and muscle were collected for the 
chemical lead analysis. These tissues were stored at -20 C 
until tested, 
'^Coulter Electronics, Inc., Hialeah, Florida. 
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Histopathological Procedures 
The tissues collected at necropsy were fixed in 10 per 
cent buffered formalin. All tissues were dehydrated in 
graded ethanol solutions, cleared in xylene and embedded in 
paraffin. Sections were cut at 6 and mounted with 
Permount^  mounting medium on glass slides. All sections 
were stained with Harris's hematoxylin and eosin (H and E). 
Some selected tissues were also stained by Ziehl-Neelson 
acid fast stain. These procedures were carried out as 
described in the Armed Forces Institute of Pathology's 
Manual of Histologic Staining Methods (115). 
F^isher Scientific Company, Pair Lawn, New Jersey, 
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EXPERIMENTAL PROCEDURES AND RESULTS 
Experiment I: The Effect of Interferon and 
Statolon on the Survival of Chickens 
Inoculated with Marek's Disease Virus (MD-JMV) 
Kinetics of interferon production in chickens by statolon 
Four-day-old chickens were inoculated intraperitoneally 
(I.P.) with statolon at the dosage level of 0^0 mg/kg. Six 
chickens were exsanguinated by cardiac puncture at each of 
the following times; 0. 2, 6. 12. 24. 48. 72 and 96 hours 
postinoculâtion. The sera of the chickens bled at each 
time interval were pooled and stored at -20 C until assayed 
for interferon by the plaque-reduction method, 
MD-JMV virus titration 
Tenfold serial dilutions of virus were made in BME 
mofi Ï nm •utt rVi o • q Qolra «PiiTr» r.o-nt-.Vi c mf" m via m'l r\-f' 
dilution of the virus was inoculated I.P. into six four-day-
old chicks free of KDV antibodies. The LDen titer of the 
virus was calculated using the Reed and Muench method (139). 
Effect of exogenous interferon 
Four-day-old chicks were divided into four groups con­
taining 27 or more chicks per group. Each group was 
inoculated I.P. with 0.2 ml of HD-JnV virus containing 
39 LD^ o* Three of the above groups received 0,5 ml of 
concentrated crude interferon preparation I.P. for 14 
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consecutive days as indicated below. The interferon titer 
was 2048, 50 per cent dye-uptake units per ml (DU^ oy^ i). 
Interferon administration was initiated simultaneously with 
virus in the first group 72 hours after virus inoculation 
in the second group and 168 hours following virus inocula­
tion in the third group. The control group received allan­
toic fluid from 14=day-old uninfected chicken embryos, 
Effect of statolon 
The experiment described below was performed twice. 
All the four-day-old chicks in this trial were inoculated 
with 39 LD^ o MD-JMV I.P. In the first trial seven groups 
of 36 or more chicks per group received a single dose of 
500 mg/kg statolon I.P. at different times. Chicks of the 
first group received statolon six hours before virus in­
oculation and other groups at 0, 6, 24, 48 and 120 hours 
after virus inoculation. 
In the second trial eight groups of 32 or more chicks 
per group received a single dose of 500 mg/kg statolon at 
different times. Chicks of the first group were inoculated 
at 2'a- hours before virus and the other groups at Oj 6j 24. 
48, 72 and 96 hours postinoculât ion. 
Control chicks received 0.25 ml of BME media with 
Earless salts intraperitoneally. 
Chicks that died during the course of the experiments 
were necropsied. The experiment was terminated six weeks 
5? 
after virus administration at which time surviving chickens 
were killed and necropsied. 
Results 
Kinetics of interferon induction 
Low levels of circulating interferon were detected in 
chicks bled at six hours postinduction. The maximum titer 
of 128 was detected in serum 24 hours after induction and 
decreased thereafter. The results are presented in Table 1. 
The viral inhibitor, produced in the chicks by statolon. 
was characterized as being acid-resistant non-dialyzable 
and species specific. 
Table 1. Serum interferon titers in chicks given intra­
peritoneal injections of statolon 
Interferon titers^ per ml 
i of ï on \ 
Inducer 0 2 6 12 24 48 72 96 
Statolon 0 0 2 4 128 64 16 0 
500 mg/kg 
I^nterferon titers are expressed as the reciprocal of 
the dilution which produces a 50 per cent reduction in the 
number of viral plaques. 
MD-JMV virus titration 
The inoculation of MD-JMV at lower dilutions into 
chicks was characterized by death occurring as early as 
six days postinoculâtion and as late as 12 days. The exper­
iment was terminated six weeks after virus inoculation. 
Table 2, Mortality data of chickens inoculated with 
MD-JMV 
Virus Mortality Total Total Per cent 
dilution ratio deaths survival death 
10-1 6/6 25 0 100 
10-2 6/6 19 0 100 
10"^  6/6 13 0 100 
1 o
 
1—1 
6/6 7 0 100 
1 o
 
r
H 
1/6 1 5 17 
-6 
n /K 
^ ^ 10 0 Q 
10"? 0/6 0 17 0 
The MD-JMV virus titer calculated by the Eeed and Muench 
method (139) was 39810 LD^ q per 0,2 ml 0 
The effect of exogenous interferon 
The I.P. inoculation of 39 LD^ g MD-JMV into four-day 
old control chicks resulted in 96.7 per cent mortality. 
A survival rate of 17.3 per cent was observed when I.P. 
interferon administration (1024 DUcq units per dose) was 
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initiated simultaneously with virus. When exogenous inter­
feron administration was started 72 hours after virus 
inoculation, only 7.4 per cent of chicks survived. Inter­
feron treatment at 168 hours after virus inoculation, at the 
time when the first chicks started to show clinical signs and 
die, neither protected nor prolonged the survival of the 
chicks. The results are summarized in Table 3. 
A statistical analysis by the chi-square test (153) 
indicated no significant difference (P<0,05) between 
chicken survival in the interferon-treated and the control 
groups, 
Death in chicks in interferon-treated and control groups 
occurred at 7 to 13 days after viral inoculation. Depression 
and weakness were observed only for four to five hours 
before death. 
No macroscopic lesions typical of Marek's disease were 
observed during the necropsy. 
The effect of statolon 
The effect of statolon on the survival of chicks 
inoculated with MD-JMV was marked. The time of statolon 
administration was critical. 
In the first trial statolon administered six hours 
prior to virus inoculstion protected 21,1 per cent of the 
chicks as compared to 5 per cent survival in the control 
groupc Simultaneous I.?, injection of sfcafcolon and virus 
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protected 26,3 per cent. Fifty per cent protection was 
observed when statolon was given six hours after viral 
inoculation. The maximum protection rate of 56«8 per cent 
was achieved when statolon was administered 24 hours after 
the virus. When statolon was given 4-8 hours post inoculât ion, 
the rate of survival in chicks decreased to 32.4 per cent. 
No protection was observed when statolon was administered 
120 hours after the virus. 
The preceding experiment was repeated and similar 
findings were observed. The best protection was again 
achieved when statolon was administered 24 hours after 
virus. The protective effect of statolon diminished when 
it was given later. The results of both trials are sum­
marized in Table 3« 
A statistical analysis by the chi-square test indicated 
significant differences {?<0,05) between chicken survival in 
statolon-treated and control groups except when statolon 
was administered 96 hours or later after the virus. 
Death in chickens in statolon-inoculated and control 
groups occurred at ? to 14 days after viral inoculation^ , 
Depression and weakness were observed only four to five 
hours before death. 
Macroscopic lesions typical of Karek^ s disease were 
not observed in the necropsied chickens. 
S u r v i v a l  d a t a  
Treatment 
Interferon 
Control c 
Statolon d 
Control 
No, survived/No. inoculated Survival % 
Trial 1 Trial 2 Trial 1 Trial 2 
simultaneously with virus 
72 hours after virus 
168 hours after virus 
24 hours before virus 
6 hours before virus 
simultaneously with virus 
6 hours after virus 
Zk hours after virus 
48 hours after virus 
72 hours after virus 
96 hours after virus 
120 hours after virus 
5/29 
2/27 
0/28 
1/30 
8/38 
10/38 
18/36 
21/37 
12/37 
1/40 
2/40 
4/33 
17/36 
9/32 
17/33 
8/32 
4/32 
0/32 
0/36 
39 LD^ g intraperitoneally. 
D^ally for 14 days 1028 DU50 units intraperitoneally, 
N^ormal allantoic fluid 0,5 ml. 
S^ingle dose $00 mg/kg I.P. 
17.3 
7.4 
0 
3.3 
21.1 
26.3 
50.0 
56.8 
32.4 
2.5 
5.0 
12.1 
47.2 
28.1 
51.5 
25.0 
12.5 
0 
0 
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Experiment II : Lead Poisoning in Chickens 
Six-week-old chickens of both sexes were divided at 
random into groups containing twelve chickens each. Chickens 
were given lead acetate dissolved in water individually per 
OS daily for 35 consecutive days. Two separate trials were 
conducted. In trial one the control group received no lead 
and the remaining three groups received 20 mg/kg, 40 mg/kg 
and 80 mg/kg respectively. In the second trial the control 
group received no lead and the remaining three groups 
received 160 mg/kg, 320 mg/kg and 640 mg/kg of lead respec­
tively. 
All chickens were individually weighed prior to and 
after the treatment. Group mean weight was used in deter­
mining the quantity of lead used for treatment. Equal 
quantities of blood were obtained from all chickens within 
each group and the blood W&S pooled to glrOupo 
The chickens were bled on the 10th, 21st and 30th day after 
treatment initiation for the determination of lead levels 
in blood. The blood of four chickens selected at random 
from each of the treatment groups was used for hematological 
studies. White-and red-blood-cell counts, packed cell 
volume, hemoglobin determinations and differential leuko­
cyte counts were determined on the 15th and 30th days after 
lead treatment began. 
Four chickens selected at random from each of the 
treatment groups were necropsied at 35 days after lead 
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administration and lung, liver, kidney, brain, femur and 
gastrocnemius muscles were collected for the chemical analy­
sis. Liver, kidney and lung samples were used for histo-
pathological studies. 
All chickens were necropsied at the time of death. 
Results 
Chickens tolerated levels of lead (Table 4 ) as high as 
160 mg/kg for 30 days administered per os without exhibiting 
clinical signs or hematological changes (Tables 5 and 6), 
There were no significant weight differences between control 
and lead-treated groups nor were gross lesions observed» 
Chickens treated at a level of 320 mg/kg of lead ex­
hibited early signs of lethargy, tiring, weakness and depres­
sion. Anorexia, anemia and apparent loss of weight followed 
and marked paralysis of both legs «-w/i «ings îîsls observed in 
most birds a day or two prior to death. One chicken in the 
320 mg/kg treatment group died on the 11th day and five 
others at 21-30 days following initiation of lead treatments 
Six chickens of this group survived and all but one showed 
depression, anemia and loss of weight. The total erythro­
cyte counts and the leukocyte differential counts remained 
within normal limits after 30 days of treatment, A fall 
in hemoglobin concentration was noted in chickens after 15 
days of treatment and all chickens had decreased levels of 
hemoglobin after 30 days of treatment (Table 6), The PCV 
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remained within normal limits in all tested chickens except 
chicken number 2? (Table 6), Examination of blood smears 
indicated increased numbers of the immature erythrocytes. 
Basophilic stippling of erythrocytes was not seen. Anemia 
and emaciation were constant findings during necropsy. 
Chickens at the 640 mg/kg lead level showed a high 
mortality rate. The first chicken died on the sixth day 
after lead administration started, nine deaths occurred 
between days 11 and 21, one chicken died on day 28 and the 
last one on day 34, The clinical signs were similar to those 
described above. The number of erythrocytes and leukocyte 
differential counts remained within normal limits. The 
number of leukocytes was slightly increased as compared to 
the control chickens (Table 6). The packed cell volume was 
decreased in chicken number 32, Hemoglobin concentration 
was markedly decreased in all chickens with chicken number 
32 showing a low of 2,1 gm/100 ml (Table 6), Blood smears 
revealed approximately 12 per cent of immature red blood 
cells, some of which were in various stages of mitotic 
division (Figure 1), Changes in cell shape and enucleated 
or binucleated cells were common. At necropsy chickens 
were found to have severe anemia and emaciation and all of 
them weighed I50 to 250 g in comparison to 750-1,000 g for 
the control group. At necropsy a few chickens showed 
absence of any fatty tissue and discolorated^  edematous liver. 
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Chemical analysis of tissue specimens revealed that 
significant quantities of lead were present in the tissues 
of lead-treated chickens. A wide range in tissue lead 
concentrations was found in chickens which received the 
same lead treatment. The range of tissue lead levels within 
the same chicken was quite broad. The highest concentrations 
were found in a bone tissue in all chickens. The next 
highest lead levels were found in the kidneys. Lead deposi­
tion in liver and lung was lower than in kidneys and the 
lowest concentrations of lead were found in muscle. Gen­
erally the mean of lead content of tissues was higher in all 
tissues of chickens which were given higher doses of lead. 
Pew exceptions were observed. The mean lead concentration 
in bone tissue of chickens at the 640 mg/kg level was 
considerably lower than in chickens which were given 320 mg/kg 
and 160 mg/kg lead levels. The results are summarized in 
Table 7. 
Histopathological examination of kidney, liver and lung 
H and E sections by light microscopy did not reveal any 
specific lesions which could be attributed to the lead 
poisoning. In kidney and liver tissues of some chickens of 
the 320 mg/kg, l60 mg/kg, 80 mg/kg and 20 mg/kg groups, 
accumulations of mononuclear cells were observed. No 
particular pattern of distribution of these EE cells was 
found. 
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Acid-fast staining did not reveal nuclear inclusions 
in tissues of lead-treated chickens. 
Table 4. The concentration^ of lead in the blood of chickens 
given lead per os 
Concentration of lead (ppm)~ 
days after treatment 
Daily dose of lead 10 21 30 
Control (no lead) 0.04 0.05 0.05 
20 mg/kg 0.8 1.6 2.0 
^0 mg/kg 1.1 1.8 2.8 
80 mg/kg 1.7 2.6 4 .1  
160 mg/kg 
- 5.9 6.2 
320 mg/kg® 4.75 - 12.0 
640 mg/kg& 10.5 - -
P^ooled blood of 12 chickens. 
•u 
ppm - parts per million. 
O^ne chicken died on the 11th day, 5 chickens died 
between days 21 and 30. 
O^ne chicken died on the 6th day, 9 chickens died 
between days 11 and 21 and one died on day 28. 
Table 5. Effect of lead given per os 
chickens 
WBC„ 
XIOJ 
Dally dose of lead 
RBC, 
xlO* 
PCV 
% 
Control (no lead) 
Chicken 1 7,700 2.72 31 
2 7,500 2.65 30 
3 15,350 2,02 33 
4 15,000 2.84 39 
20 mg/kg 
5 8,500 2.87 30 
6 9,850 2.53 32 
7 6,400 3.09 35 
8 7,700 3.10 36 
40 mg/kg 
10,400 9 2.18 32 
10 19,300 
2.94 11 5,900 29 
12 7,000 2.98 29 
80 mg/kg 
13 12,950 2.85 " 
14 15,700 3.05 «0 
15 10,250 2.11 28 
16 7,300 2,84 32 
for 30 days on hematologic changes in 
Hb Lympho- Eoslno- Baso- Hetero- Mono-
gm/lOOml cytes phils phils phils cytes 
^ ^ ^ ^ 
8,6 67 3 1 26 3 
8.9 61 4- 3 31 1 
8.9 80 1 2 13 4 
11.9 65 7 3 25 1 
8.9 74 1 4 19 2 
8.3 56 6 3 33 2 
9.1 69 4 4 17 6 
8.6 63 3 4 30 0 
8.0 51 8 3 36 2 
9.1 46 7 1 44 2 
8.0 70 2 3 23 2 
8.0 70 1 3 26 0 
8.0 53 1 1 43 2 
8.9 51 3 2 42 2 
7.2 50 7 4 37 2 
7.7 61 3 6 29 1 
Table 6, Effect of lead given per os for 30 days on hematologic changes in chickens 
Daily dose of lead 
WBG_ 
xlo3 
RBG. 
xior 
PCV Hb LymphO" Eosino-
% gm/lOOml cytes phiis 
BasO" Hetero- Mono-
phils phils cytes 
 ^  ^  ^
Chicken 17 12,800 2.72 35 9.8 65 4 5 25 1 
18 8,700 3.10 30 10.1 59 2 4 34 1 
19 9,850 2.25 35 8.9 72 5 3 19 1 
20 7,600 2.28 31 8,6 51 8 6 35 0 
160 mg/kg 
21 14,350 3.07 32 8.3 55 3 6 36 0 
22 8,200 2.54 8.2 69 3 10 17 1 
23 8,450 2.82 32 8.3 60 5 7 25 3 
24 9,650 2.56 34 9.8 77 1 8 14 0 
320 mg/kg* 
63 25 9,000 2.52 33 7.7 3 12 22 0 
26 5,650 2.50 35 6.9 40 6 15 37 2 
27 15,000 2.28 24 4,7 54 6 1 38 1 
28 9,250 2.25 30 7.4 56 2 9 30 3 
640 rag/kg^  
41 29 13,800 2.49 30 5.1 48 6 2 3 
30 12,600 2.53 30 5.4 56 2 2 32 8 
31 17,280 2.20 31 7.2 50 3 7 38 2 
32 15,000 2,33 27 2.1 54 2 2 38 4 
C^hicken number 26 died on day 21 and hematologic changes given are those 
observed after 15 days of treatment, 
C^hickens number 29, 31 and 32 died between days 15 and 21 after initiation 
of treatment. Results reflect observations made after 15 days of treatment. 
Table 7. The concentration of lead in tissues of chickens^  given lead per os for 
35 days. 
Daily dose of lead ger os 
20 mg/kg_ 40 mg/kg 80 mg/kg 
Concentration of lead (ppm) in tissues 
Tissue Mean Range Mean Range Mean Range 
Brain 'JA 0.0- 11.5 8.9 5.0- 15.0 7.8 3.5" 15.0 
Lung 1.9 0.0- 5,0 8.1 2.8- 12.5 4.4 2.5" 7.1 
Muscle 1.3 0.0- 3.8 5.1 1.3- 9.1 3.1 0.0- 4.9 
Kidney 4.9 0.0- 10,0 10.8 6.3- 14.1 11.2 6.2- 17.5 
Liver 2.1 0.0- 7.5 9.5 4.7- 20.0 7.7 2.5" 12.5 
Bone 65.7 17.0-112.5 166.9 105.8-294.6 282.6 211.5-338.8 
*Pour chickens per treatment group. 
Table ?• (Continued). 
160 320 mg/kg 64g_m&/kg^  
Concentration of lead (ppm) in tissues 
Tissue Mean Range Mean Range Mean Range 
Brain 7.3 3.1- 13.8 14.8 12.5- 16.3 15.4 10.4- 25.0 
Lung 6.3 1.9- 12.5 16.9 7.5- 25.0 77.3 8.3-222.2 
Muscle 4.2 0.0- 9.1 10.6 0.0- 34.7 13.7 3.8- 22.5 
Kidney 11.2 10.0- 14.3 49.8 10.7-141.7 152.1 47.2-345.8 
Liver 7.2 3.1- 13.9 18.9 7.1- 44.4 78.9 71.3" 91.6 
Bone 438.1 290.9-512.0 494.8 290.5-650.0 310.5 190.0-396.9 
C^hickens of this treatment group died between days 12 and 18 after in­
itiation of lead treatment. 
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Figure 1. Blood smear of a chicken which received 
lead acetate (640 mg/kg) for 30 days, "Note immature 
erythrocytes and mitotic figure, xl680 
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Experiment III: The Effect of Lead on Interferon 
and Antibody Production in Chickens 
Interferon induction in chickens 
Statolon, polyl'polyC and the viruses PEV-D2> SIV and 
NDV-B 1 were used as interferon inducers. 
Nine groups consisting of three ten-week-old chickens 
per group were inoculated using different routes and doses 
of interferon inducers (Table 8). Chickens were bled at 0, 
2, 6, 24 and 48 hours after induction. Blood of the chickens 
from the same treatment group was pooled and serum was 
assayed for interferon using the plaque-reduction method. 
Effect of lead on interferon and antibody production 
Statolon (500 mg/kg) and NDV-B% (1024 HA/kg) were.admin­
istered I.V. as interferon inducers. Twelve ten-week-old 
chickens from each group that previously received lead at 
the rate of 20 mg/kg, 40 mg/kg, 80 mg/kg or 160 mg/kg for 
30 days per os were divided into two equal groups. Six 
chickens were inoculated with statolon and six with NDV-B^ • 
Only NDV-B^  was used as an interferon inducer in the -group 
of six chickens which received lead at the 320 sig/kg level 
for 30 days. 
Lead treatment was continued at the previous regimen 
until termination of this experiment. 
Chickens inoculated with statolon were bled at 0, 2, 
6, 24, 48, 72 and 100 hours postinduction»_ Chickens which 
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received NDV-B^  were bled at 0, 6, 24, 48, 72 and 100 hours 
after virus inoculation. Blood of chickens from the same 
treatment group was pooled and serum was assayed for inter­
feron using the plaque-reduction method. 
The viral inhibitor produced in chickens was examined 
for dialysability, sensitivity to trypsin, acid and heat 
sedimentation by centrifugation at 100,000g for 60 min. and 
species specificity. 
Chickens which were inoculated with NDV-B]_ were bled 
14 days after virus inoculation. Blood samples were col­
lected for lead determination and serum was tested for NDV 
antibodies using the HI test. 
Results 
Interferon induction in chickens 
Titers of interferon in serum were determined after the 
administration of the interferon inducers by various routes 
and the results are summarized in Table 8, ?olyI*polyC, 
SIV and PRV-DR were not effective inducers of interferon at 
the doses used, Statolon at the 5® mg/kg dose level in­
duced low titer interferon at six hours postinduction. 
Statolon at the ^ 00 mg/kg dose level and NDV-B were 
effective interferon inducers. 
Effect of lead on interferon and antibody production 
Lead treatment of chickens at the 20 mg/kg, 40 mg/kg, 
BO mg/kg and 160 mg/kg levels did not affect interferon 
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production induced by statolon. Neither interferon con­
centration nor duration of detectable interferon in serum 
were markedly changed as compared with the controls. 
Interferon production in response to NDV-B^  was not 
affected in chickens treated at the 20 mg/kg, 40 mg/kgand 
80 mg/kg lead dosage levels. Lead treatment of chickens at 
the l60 mg/kg level slightly decreased interferon concen­
tration induced by NDV-B^ » 
All but one of the chickens in the 320 mg/kg group 
showed some signs of lead poisoning at the time of inocu­
lation of interferon inducer. Interferon concentrations 
and duration in serum were markedly decreased in chickens 
of this group. The results are summarized in Tables 9 and 10. 
The viral inhibitor produced in chickens by statolon 
and NDV-B^  stimulation was characterized as being acid-resis-
tant, non-dialyzable J non-sediisentabla at ICCjOOOg for 6c 
sin,, trypsin sensitive, heat stable and species specific» 
The results are summarized in Table 13= 
Long-time lead exposure had no marked effect on anti­
body production to NDV-B^  in chickens. No consistent 
correlation was observed between blood lead concentration 
and antibody titers. 
Three chickens out of six which were on the 320 mg/kg 
lead treatment died between days 35 and 40 after initiation 
of lead treatment. All three surviving chickens shotred 
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signs of lead poisoning and only chicken number 71 had a 
markedly lower antibody titer than the untreated chickens. 
The results are summarized in Tables 11 and 12, 
Table 8. Induction of interferon in chickens by various 
interferon inducers 
Interferon titer 
hours postinoculâtion 
Inducer Dosage Route 0 2 6 24 48 
Polyl'polyC 0. 1 mg/kg I.V. 0 8 8 < 8 
0. 05 I.V. 0 8 < 8 <8 
1 wing web 0 
oo V
 
00 
<8 <8 
5 wing web 0 - <8 <8 < 8  
Statolon 50 I.V. 0 8 <8 <8 
500 I.V. 0 - 256 128 8 
PVR-DR^  1 ml/kg I.V. 0 - < 8 < 8 <8 
SIV 640 HA/kg I.V. 0 8 <8 <8 
NDV-B^  2048 HA/kg I.V. 0 - 256 256 32 
P^RV-DR titer 3.2 x 10^  pfu/ml . 
76 
Table 9. Effect of lead on interferon production in chickens 
Inducer 
Daily dose of lead 
for 30 days 
Interferon titer 
hours postinoculâtion 
2 6 24 72 100 
Statolon Control (no lead) 0 64 64 16 8 4 0 
500 mg/kg I.V. 20 mg/kg 0 16 64 32 8 4 0 
40 mg/kg 0 128 64 16 4 2 0 
80 mg/kg 0 64 128 8 8 4 0 
NDV-B, 
1024 HA/kg I.V. Control (no lead) 0 - 64 128 32 8 4 
20 mg/kg 0 - 128 64 64 4 4 
40 mg/kg 0 - 32 - 32 16 0 
80mmg/kg 0 
-
64 256 32 8 4 
Table 10. Effect of lead on interferon production in chickens 
inaucer 
Daily dose of lead 
for- 30 days 0 
Interferon titer 
hours postinoculâtion 
2 6 24 48 72 ICQ 
Statolon 
500 mg/kg I.V, 
Control (no lead) 0 256 64 I6 32 4 
160 mg/kg 0 256 1 oQ 1 ^  
4 
o 
NDV-Bx 
1024 HA/kg I.V. Control (no lead) 0 
160 zg/kg 0 
320 mg/kg 0 
128 512 256 32 16 
64 256 32 4 4 
16 64 8 0 0 
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Table 11, Effect of low lead levels on antibody titer to 
NDV-B^  in chickens 
Chicken HI antibody Lead concentration 
No. Daily dose of lead titer^  in blood (ppm)*^  
33 Control (no lead) 128 0,05 
3^  128 0.25 
35 512 — 
36 256 
37 512 -
38 512 -
39 20 mg/kg 128 2.00 
4-0 256 1.45 
41 256 3.27 
42 512 2.40 
43 256 — 
44 256 -
45 40 mg/kg 512 3.20 
46 128 2.50 
47 128 1.95 
48 256 2.25 
49 64 3.65 
50 256 2.40 
51 80 ag/kg 128 3.30 
52 256 4,45 
53 64 4.75 
54 128 5.55 
55 64 8.00 
56 128 4.40 
°0n the l4th day after NDV-B^  inoculation. 
A^fter 44 days of lead administration per os. 
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Table 12. Effect of high lead levels on antibody titer to 
NDV-Bi in chickens 
Chicken HI antibody Lead concentration 
No. Daily dose of lead titer& in blood (ppm)° 
57 Control (no lead) 128 0.25 
58 128 — 
59 128 — 
60 128 es 
61 64 0.20 
62 256 -
63 160 mg/kg 128 6.55 
64 128 _ 
65 256 5.25 
66 256 6.40 
67 128 5.70 
68 64 11.05 
69 320 mg/kg 128 9.00 
70 128 10.85 
71 32 13.64 
^On the l4th day after NDV=Bt inoculation. 
A^fter 44 days of lead administration per os. 
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Table 13. Properties of chicken interferon 
Treatment 
. R e s u l t s  
Induced by Induced by 
statolon NDV 
1. Dialysis for 48 hours at 4 C 
2. Acidification at pH 2 
3. Trypsin sensitivity 
Control titer 
Trypsin ( 2 ug/ml ). for.-2 'hour# 
at 37 C 
Non-dialyzable 
Activity retained 
Activity destroyed 
64 . . 128 
4. Heat stability 
Control titer 
Titer after heating at 6^ C 
for 60 min. 
Heat stable 
64 64 
64 64 
5. Ultracentrifugation (100,000g/60 min.) Non-sedimentable 
Titer before centrlfugation 32 l6 
Titer after centrifugation 32 16 
6, Activity against VSV in 
heterologous cells 
Titer on CEP 
Titer on MDBK 
Not active 
64 64 
0 2 
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DISCUSSION 
There is good evidence that interferon and interferon 
inducers exert an antitumor effect in tumors caused by 
oncogenic viruses (73, 105, 108, 125, 130, 134, I60, 175), 
transplantable tumor cells (7^ ) or chemical carcinogens (111). 
Neoplastic diseases caused either by DNA 1^25, I60) or RNA 
(73, 105, 130, 134', 175) viruses have been reported to be 
repressed by interferon or interferon inducers. 
Very little work has been reported in the literature 
on the effect of interferon and interferon inducers on 
oncogenic viruses in chickens. Nemes ^  al. (123) reported 
that repeated inoculations of polyI»polyC partially pro­
tected chickens against Bous sarcoma virus (ESV) but not 
against MDV. Exogenous interferon inhibits replication of 
RSV and lymphoid leukemia virus ^  vitro and inhibits 
development of tumors induced by these viruses in chickens 
(105). Lampson e;t a2. (IO6) reported that crude and 
purified chicken interferon produced in chick embryos was 
active in suppressing Rous sarcoma development but was 
without therapeutic effect once infection was established. 
In this study (Experiment I) the prophylactic and 
therapeutic effect of interferon and statolon in chickens 
given 39 LD^ o of MD-JMV I.P. was investigated. 
The repeated administration of crude exogenous 
81 
interferon preparations increased the percentage of surviving 
chickens when administration was initiated simultaneously 
with virus. A survival rate of 17,3 per cent was observed. 
When interferon treatment was started 72 hours after viral 
administration, only 7.^  per cent of the chickens survived. 
If interferon administration was initiated l68 hours after 
virus, at the time when chickens started to show clinical 
signs of the disease, interferon neither protected the 
chickens nor prolonged their survival when compared with 
controls. Fewer than 4 per cent of the birds survived in 
these two groups, 
A statistical analysis by the chi-square test indicated 
no significant difference (?<0,05) between survival in the 
interferon-treated and control groups, A survival rate of 
17,3 per cent was observed in chickens when administration 
of interferon was initiated simultaneously with virus. The 
survival of one additional chicken in this group lîculd have 
made the survival rate in the interferon-treated group 
statistically significant. Individual variation in the 
weight of chickens and their susceptibility to KDV, as well 
as possible minute variations of administered virus dosage, 
could have affected their survival. 
Generally the percentage of surviving chickens decreased 
as interferon treatment was initiated at successively longer 
periods after virus inoculation. The biological data col­
lected in this experiment show that interferon at the 
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concentrations used may have prophylactic value but is with­
out any effect once infection is established. 
Statolon has previously been shown to be an effective 
inducer of interferon in chickens (56, 132). In this study 
(Experiment I) statolon induced low levels of circulating 
interferon at six hours postinoculâtion in four-day-old 
chicks, A maximuni titer was detected in serum 24 hours after 
induction and then decreased. No circulating interferon was 
found at 96 hours postinoculâtion, 
Statolon is known to be effective in protecting mice 
against Friend-virus leukemia even after the disease is 
established (175» 176), Statolon treatment tends to convert 
leukemia into a persistent, inapparent infection (176), 
Statolon given systemically protects chickens against avian 
influenza (132) and has a prophylactic effect against MDV 
when inoculated into baby chicks (I6), 
In this study chicks infected with MD virus exhibited 
various degrees of resistance depending upon the time of 
statolon administration. Statolon given at 24 and 6 hours 
administered simultaneously with virus. In the first trial 
statolon inoculated six hours after virus protected more 
chicks than when given simultaneously with virus. However, 
in the second trial simultaneous administration of virus 
and statolon resulted in a higher percentage of surviving 
chicks than in a group when statolon was given six hours 
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after- virus inoculation. In both trials the maximum pro­
tection was achieved when statolon was given 24 hours after 
virus. The survival rate was 36.8 and 51.5 per cent re­
spectively as compared with five and zero per cent in the 
control groups. The protective effect decreased when stato­
lon was administered 48 hours or more after virus inoculation,. 
The lack of protection against MDV resulting from 
repeated administration of polyI®polyC in chickens (123) 
can be attributed to the fact that polyl'polyC is a very 
poor interferon inducer in chickens (56, 132), PolyltpolyC 
also showed very weak protection against ESV (123), whereas 
exogenous interferon suppressed Rous sarcoma development 
(105, 106). However, the presence of lesser amounts of 
interferon or the absence of detectable circulating inter­
feron is not always indicative of protection or lack of 
protection (56). Synthetic polynucleotides have been shown 
to induce cellular resistance in the absence of detectable 
interferon production (169). Viral resistance conferred 
by stimulation of the interferon system depends upon the 
interferon sensitivity of the test virus, the target cells 
or organ infected and the nature of the interferon inducer 
used (5é)« The route of administration of the inducer is 
also a very important factor (56)0 Since the antitumor and 
antiviral mechanism of poiyI®polyG is'multifaceted (5, 111), 
it is difficult to explain why polyI»polyC does not protect 
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chicks against RSV and MDV. Since interferon plays a very 
important role in protecting chicks against these viruses, 
it may be concluded that the poor interferon-inducing capa­
city of polyl'polyC in chickens is the reason for the lack 
of protection. 
It is likely that the protective effect of statolon 
against MD-JMV in chicks is due not only to interferon. 
Detectable circulating interferon was present only for three 
days after statolon administration and yet the protective 
effect of statolon persisted beyond this time. 
Recent findings show that the mechanism of antitumor 
and antiviral action of interferon and interferon inducers 
may be multifaceted (5, 111). Wheelock e^  al. (177) in­
dicated that the antitumor effect of statolon might be due 
to its capacity to restore immuno-competence in mice infected 
with Friend virus. It is possible that statolon-induced 
interferon delays MD virus replication briefly permitting 
some chicks to mobilize an effective immune response. The 
crucial factor determining the outcome of the MD-JMV in­
fection is the time of statolon administration. Since the 
kinetics of MD virus replication and the mechanism by which 
it causes symptoms and death are not elucidated, it is 
difficult to state why statolon is effective when administered 
over a wide range of time before or after virus inoculation. 
Statistical analysis of the experimental data shows that 
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inoculation of the inducer from 24 hours before virus in­
oculation up to 72 hours after virus inoculation signifi­
cantly protects chicks against MD-JMV. 
It is known that Marek's disease virus is a typical 
cell-associated virus (36, 121, 155) which spreads slowly 
and in cell cultures appears to spread directly from cell 
to cell (36). It seems possible that interferon induced by 
statolon effectively interferes with virus replication at 
the early stages of infection and prevents virus spread to 
vital organs. Experimental data indicates that statolon 
is most effective when administered from 6 to 24 hours after 
virus inoculation. It is obvious that some unknown step 
of virus replication is very sensitive to statolon at this 
time. Interferon, which is at maximal concentration at 24 
hours postinduction, prevents further replication and spread 
of virus, 'The fact that statolon-induced interferon is 
detectable in serum for three days explains the protection 
of chicks inoculated with statolon even 72 hours after virus 
inoculation. Statolon inoculated at 96 hours after virus 
injection did not protect chicks probably because MD virus 
had already reached and damaged vital organs. The first 
chicks started to die on the seventh day (I68 hours) after 
virus inoculation. 
The biological data collected in this experiment show 
that statolon has a prophylactic value in protecting chicks 
against MD-JMV, The therapeutic value of statolon at the 
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dose used was insignificant. 
Reports in the literature (99) implicate other herpes­
viruses as oncogenic agents in humans. In view of the above 
findings statolon at higher doses may be of therapeutic 
value in treatment of neoplastic disease in man. 
There is very little published information on the 
effects of lead in chickens» Signs of poisoning including 
drowsiness, thirst, loss of appetite and diarrhea ascribed 
to the feeding of lead arsenate were described in 1932 
(159). Salisbury ^  al. (144) reported lead poisoning in 
adult chickens caused by feeding a grit which contained 
lead oxide. These authors observed a marked loss of weight 
in all birds, cessation of egg production, severe anemia 
and high mortality. Most of the chickens were found to 
have a severe necrosis of the gizzard lining. Experiments 
with young chickens showed that rhe susceptibility to lead 
intoxication decreases with age (144), Simpson al, 
(151) described abnormalities of erythrocytes and renal 
tubules of chickens poisoned with high doses of lead. 
Approximately 24 per cent of erythrocytes were immature 
and approximately two per cent of the immature red blood 
cells were in various stages of mitotic division. By 
light microscopy, necrosis of the epithelium of the proximal 
convoluted tubules of the kidney was observed and by electron 
microscopy, the nuclei of these cells were seen to contain 
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irregularly shaped, electron-dense inclusions (151). 
Most published reports on lead poisoning in birds 
have been about its toxicity in wild fowl (6, 7, 38, 90). 
The effects of lead given per os to chickens for 35 
consecutive days was investigated in this study (Experi­
ment II). 
Chickens tolerated levels of lead as high as 160 mg/kg 
without exhibiting clinical signs or hematological changes 
in spite of very high levels of lead in the blood. 
Analysis of lead in the blood is generally considered 
to be the best single test for the antemortem diagnosis of 
lead poisoning. Lead concentrations of pooled blood samples 
of twelve chickens which were given l60 mg/kg of lead for 
30 days was 6,2 ppm. It is apparent from this data that 
chickens are more resistant to lead poisoning than humans, 
horses, dogs and wild fowl such as ducks. Ths upper limit 
for lead in human blood is subject to some disagreement. 
Some believe it to be approximately 0.8 ppm..but others 
believe it to be less especially in young children (31, 
143). Lead poisoning has been confirmed in cattle having 
blood lead levels as low as 0,35 Ppm in both experimental 
and naturally-occurring cases (20). Horses appear more 
susceptible to lead poisoning than cattle (3). The upper 
limit for blood lead in dogs is 0,35 PPni (181), Wild water­
fowl are very susceptible to lead poisoning. Daily 
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administration of aqueous lead nitrate solution per os at 
the dosage level of 12 mg/kg killed all experimental ducks 
within a month (38). No data was found in the literature 
describing blood lead levels in wild gallinaceous birds. 
Pheasants that died of lead poisoning were reported to 
have 168 ppm of lead in their livers and 42 ppm in the 
breast muscles (90). Tissue lead levels reported in Canada 
geese poisoned by lead were much lower (6). 
The evidence cited above suggests that gallinaceous 
birds are relatively resistant to lead poisoning, however, 
to confirm this statement, more detailed comparative studies 
are needed. 
The present study suggests that chickens can tolerate 
a 6,2 ppm level of blood lead without evidence of intoxi­
cation, hematological changes or death. 
Fifty pejr cent of oriiokeiis treated at a Isad level of 
320 mg/kg died within 30 days» All but one of the chickens 
receiving 64-0 mg/kg lead died within 30 days. The clinical 
signs included weakness, depression, anorexia, anemia and 
loss of weight, A marked peripheral paralysis was observed 
in most chickens a day or two prior to death. In contrast 
to other reports (159)j no diarrhea was observed. Hemo­
globin concentration was markedly decreased in all chickens 
of the 320 mg/kg and 640 mg/kg lead-treatment groups. 
Examination of blood smears revealed increased numbers of 
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immature erythrocytes, some of which were in various stages 
of mitosis. Poikylocytosis, anisocytosis and enucleated 
or binucleated cells were common, Simpson e^  al. (I5I) 
reported similar changes in erythrocytes of chickens 
poisoned with high doses of lead. Basophilic stippling 
of erythrocytes was not observed. This finding is in agree­
ment with other published reports about lead poisoning in 
birds (38, 144, I51). Since lead interferes with heme 
synthesis (3I, 171), anemia is the functional effect of 
lead poisoning on blood. The decrease in heme synthesis 
leads at first to a decrease in the life-span of BBC and 
the amount of hemoglobin per cell (171). In compensation 
the blood-forming tissues step up their production of BBC 
and immature forms of cells appear in the circulation (31, 
171). The slight increase observed in the white blood 
blood cells which closely resemble leukocytes. 
At necropsy chickens were found to have severe anemia, 
emaciation and a marked loss of weight* Chickens of the 
640 mg/kg lead level group weighed 150-250g compared to 
750-l,000g for the control group. Absence of fatty tissue 
and discolored, edematous liver were found in some chickens. 
No macroscopic lesions were observed in the gizzard. 
Apparently if lead is given in a form which would not be 
retained in the gizzard, no severe necrosis develops in 
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the gizzard lining. 
Chemical analysis of tissue specimens revealed that 
significant quantities of lead are present in tissues of 
lead-treated chickens. Deposition of lead in the tissues 
showed variation in chickens which were in the same lead 
treatment group as well as within the same chicken. The 
highest lead concentrations were found in bone (femur). The 
next highest lead levels were in the kidney. The lowest 
concentrations of lead were found in muscle. Generally thé 
mean lead content was higher in all tissues of chickens 
which were given higher doses of lead. However, the mean 
lead concentration of femur in chickens receiving the 640 
mg/kg lead dose was 310.5 ppm. The mean lead.concentration 
of bone tissue in chickens which were given 320 mg/kg and 
160 mg/kg of lead was 494.8 ppm and 438.1 ppm respectively. 
Lead concentrations in livsr, kidney &nd lung ^ ere at least 
three times higher in the 640 ing/kg group than in the 320 
mg/kg treatment group. It was reported (7) that the degree 
of active exposure to lead is indicated by the concentration 
of the metal in liver while chronic exposure is reflected 
by relatively higher concentrations of lead in bone. 
Apparently the concentrations of lead in the bone of 320 
mg/kg and I60 mg/kg chickens reflect the longer exposure 
to lead. Tissues of chickens from these groups were col­
lected after 35 days of lead treatment, whereas, chickens 
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of - the 640 mg/kg group died of acute lead poisoning between 
12 s and 18 days after initiation of lead treatment. 
Examination of kidney, liver and lung sections by 
liglght microscopy did not reveal any specific lesions which 
cou-'uld be attributed to lead poisoning. Neither necrosis of 
the s proximal convoluted tubules of the kidney (151) nor 
int craniiclear inclusions were found. Intranuclear inclusions 
in kidney and liver have been.reported in other_species 
(6, y 72) following lead poisoning. Inclusions were not found 
evesn in acid-fast-stained tissue sections of lead-treated 
chiS-ckens in this study, 
A number of different inducers were reported to 
stUimulate production of interferon in chickens. Both DNA 
(87V7) and RNA (11, 113) viruses as well as statolon (56, 132) 
havtve "been reported as potent inducers. In contrast tilorone 
-L>ULO CUX*<  ^ U. " W ixokvo  ^ CbO 
pooor inducers, A number of interferon stimulators were used 
in this study (Experiment III): Pseudorabies and swine 
inSfluenza viruses, which induce circulating interferon in 
piggs (166), were not effective in inducing interferon in 
chii.lckens at the doses used, PolyI»polyC at the several 
dos-ses and routes of inoculation used induced very low titers 
of • circulating interferon. This finding agrees with reports 
in ithe literature (56j 132). In contrast statolon at the 
5000O mg/kg dose level and NDV-B^  I.V, were effective in 
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producing high levels circulating interferon of long dura­
tion, Because of these findings statolon and NDV were 
chosen for use in Experiment III. 
Recent studies suggest that the immunologic system 
and the interferon system may be linked (43, 75). It has 
been reported that a variety of agents and environmental 
factors like X-irradiation (^ 3) and corticosteroids limit 
antibody and interferon production, Freund's adjuvant on 
the other hand helped promote the production of antibodies 
and interferon (44). 
There is considerable evidence that lead exerts adverse 
effects upon the resistance of the body to disease by 
influencing immunologic mechanisms. Lead poisoning has 
been associated with the increased susceptibility of mice 
to Salmonella infection (81) and increased sensitivity to 
bacterial endotoxin in rats (14?) and chickens (161), Lead 
poisoning has also been associated with a decrease in the 
production (59) and inactivation (178) of antibodies. 
It has been reported that arsenicals inhibit interferon 
production and action in mice and rabbit kidney cells (62). 
Recently it was reported that lead acetate increases the 
in vivo interferon-inducing capacity of polyI*polyC when 
injected simultaneously into mice (45). The mechanism by 
which lead acetate increases the interferon response to 
polyl'polyC is not clear (45)o 
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In this study long-term lead treatment of chickens at 
the lead dosage levels used did not affect interferon 
response to statolon. Neither interferon concentration in 
the blood nor duration of detectable interferon in serum were 
changed as compared with the controls » Lead treatment of 
chickens at the l60 mg/kg level slightly decreased blood 
interferon concentration induced by NDV. The duration 
of circulating interferon was not affected. 
Only NDV virus was used as an interferon inducer in 
the 320 mg/kg chickens since 50 per cent of the treated 
birds died before administration of inducer. All chickens 
but one in this group showed some clinical signs of lead 
poisoning at the time of interferon stimulation» Interferon 
I 
response to NDV was markedly changed In concentration and 
duration. Control chickens had a maximal titer of 512 at 24 
hours postinduction and a titer of 16 100 hours post-
induction. The interferon titer of chickens of the 320 mg/kg 
treatment group reached a maximum Interferon titer of 64 at 
24 hours and no circulating interferon was found at 72 and 
100 hours postinduction. 
It appears that subclinical doses of lead of up to 
160 mg/kg for 30 days did not affect interferon production 
in chickens in response to statolon or NDV. The slight 
decreases in interferon concentration of the NDV-inoculated 
chickens could be due to variation in the ability of 
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individual chickens to produce interferon. Another possi­
bility is that lead-treated chickens do not support NDV 
replication as well as untreated chickens, Replicating 
virus in chickens has the potential to stimulate more 
interferon-producing cells and for a longer period of time. 
It is known that high interferon titers are often found at 
the tissue site of greatest viral replication (l68). On 
the other hand circulating interferon titers were not 
affected by lead treatment when statolon was used as an 
inducer. Since statolon is a non-replicating inducing sub­
stance, its interferon-inducing capacity is limited to the 
initial dose. 
The decrease in interferon concentration and duration 
observed in chickens of the 320 mg/kg group could be due to 
lead interference with many biological functions in the 
body. Lead decreases nieotinlc acid (21) and many aBlno 
acids (17), inhibits biosynthesis of DNA and ENA (103) and 
interferes with the activities of numerous enzymes (41. 101. 
170, 171)* It is obvious that interference with any of these 
biologically important functions may lead to suppression of 
interferon production. The decrease in interferon concen­
tration and duration could be due to the inability of 
lead-treated cells to support NDV replication. 
The results of this experiment indicate that subclinical 
doses of lead 6o not markedly suppress interferon production 
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in response to statolon and NDV in chickens. However, the 
effect of lead on interferon action should be further in­
vestigated. It is possible that the antiviral action of 
interferon could be suppressed or inhibited by lead poisoning 
since the mechanism of antiviral action is an involved 
process and requires synthesis of a new protein (60,  84,  
93). Without studying the effect of lead poisoning on inter­
feron action one cannot disprove or prove the statement that 
metals, by suppressing interferon, activate or induce the 
oncogenic viruses already present in the host. It is very 
possible that the suppression of interferon action is one of 
the mechanisms by which metals cause tumors, 
Long-time lead exposure had no marked effect on anti­
body production to NDV in chickens. No consistent correla­
tion was observed between blood lead concentration and anti­
body titer. Even two chickens out of three of the 520 ag/kg 
group,which showed clinical signs of lead poisoning and had 
blood lead concentrations of 9.0 and 10.85 ppm, did not have 
decreased antibody titers to NDV. The third chicken of this 
group had a blood lead concentration of 13.64 and its anti­
body titer was markedly decreased. 
The results of these studies indicate that long term 
subclinical lead intake suppresses neither interferon nor 
antibody production in chickens. One should not forget 
the fact that chickens are very resistant to lead poisoning. 
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as shown in these studies, and thus these findings may not 
be applicable to other species. 
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SUMMARY 
The effect of interferon and statolon on Marek's disease 
in chickens and the effect of lead on interferon production 
in chickens were studied. 
Pour-day-old chickens free of MDV antibodies were in­
oculated intraperitoneally with the JMV strain of MDV, Ex­
ogenous interferon induced by NDV in chicken embryos was 
administered I.P. daily for Ik days into three groups of 
chickens. Interferon administration was initiated simul­
taneously with virus in the first group, 72 hours after virus 
inoculation in the second group and l68 hours following viinis 
inoculation in the third group. A survival rate of 17.3 per 
cent was observed when interferon administration was in­
itiated simultaneously with virus. When exogenous inter­
feron administration was started 72 hours after virus 
inoculation, only 7,^  per cent of chicks survived. Inter­
feron treatment at 168 hours after virus inoculation, at 
the time when first chicks started to show clinical signs, 
neither protected the chicks nor prolonged their survival, 
Â statistical analysis by the chi^ sqnare test indicated 
no significant difference {P<0,05) between survival in the 
interferon-treated and control groups. The percentage of 
surviving chicks decreased as interferon treatment was 
initiated at successively longer periods after virus in­
oculation. 
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The biological data collected in this experiment show 
that interferon at the concentration used may have pro­
phylactic value when administered at the time of infection, 
but is without any effect once infection is established. 
The experiment on the effect of statolon on KDV in 
chickens was performed twice. Four-day-old chickens were 
inoculated with MD-JMV and a single dose of $00 mg/kg 
statolon I.P. was given at different times. The effect of 
statolon on the survival of chicks was marked and the time 
of statolon administration was critical. In both trials the 
maximum protection was achieved when statolon was given 24 
hours after virus. The survival rate was 56.8 and 51*5 per 
cent respectively as compared with five and zero per cent 
in the control groups. A statistical analysis by the chi-
squâre test indicated significant difference (P<0.05) between 
chicken survival in statolon-treated and control groups 
except when statolon was administered 96 hours or later 
after the virus. 
The data show that statolon has a prophylactic value 
in protecting chicks against MD-JMV. The therapeutic 
value of statolon at the dosage used was insignificant» 
The effect of aqueous lead acetate given per os to 
chickens for 35 consecutive days was investigated. Chickens 
were found to tolerate levels of lead as high as 160 mg/kg 
without exhibiting clinical signs or hematological changes 
in spite of very high levels of lead in the blood» The 
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lead concentration in pooled blood samples of twelve 
chickens which were given l60 mg/kg of lead for 30 days 
was 6.2 ppm. It is apparent from these findings that 
chickens are more resistant to lead poisoning than humans, 
horses, dogs and wild fowl such as ducks. 
Fifty per cent of the chickens treated at a lead level 
of 320 mg/kg died within 30 days. All except one of the 
chickens receiving 640 mg/kg lead died within 30 days. The 
clinical signs included weakness, anemia and loss of weight, 
A marked peripheral paralysis was observed in most chickens 
a day or two prior to death. Hemoglobin concentration was 
markedly decreased in all chickens of the 320 mg/kg suid 
640 mg/kg lead-treatment groups. Examination of blood 
smears revealed increased numbers of immature erythrocytes, 
some of which were in various stages of mitosis. 
Statolon (500 mg/kg) and NDV-B^  were used I.V. as 
interferon inducers in chickens which previously received 
lead at the rate of 20 mg/kg, 40 mg/kg, 80 mg/kg or loO 
mg/kg for 30 days per os. Only NDV-B^  was used as an 
interferon inducer in the group of chickens which received 
lead at the 320 mg/kg level for 30 days. In this study 
lead treatment of chickens at the dosage levels used did 
not affect interferon response to st&tolon. Lead treatment 
of chickens at the I60 mg/kg level slightly decreased 
blood interferon concentration induced by NDV, Interferon 
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concentrations and duration in serum were markedly decreased 
in chickens which received lead at the 320 mg/kg level. 
The viral inhibitor produced in chickens by statolon 
and NDV stimulation was characterized as being acid-resistantj 
non-dialyzable, non-sedimentable at 100,000g for 60 min», 
trypsin sensitive, heat stable and species specific. 
Possession of these characteristics qualifies the inhibiting 
substance as an interferon. 
Long-time lead exposure had no marked effect on anti­
body production to NDV in chickens. No consistent cor­
relation was observed between blood lead concentration and 
antibody titer. 
The results of these studies indicate that long-term 
subclinical lead intake suppresses neither interferon nor 
antibody production in chickens. One should not forget the 
fact that chickens are very resistant to lead poisoning, 
as shown in these studies, and thus these findings say not 
be applicable to other species. 
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